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 Abstract 
 
Neural development is controlled by the temporal and spatial coordination of intrinsic and extrinsic 
factors that may be brain region-specific. In this work, the regulation of postnatal hippocampal neuronal 
proliferation, differentiation and apoptosis by extrinsic factors including glucocorticoids, 
neurotransmitters and cytokines was investigated. Hippocampal and cerebellar granule neuronal cultures 
were used to identify factors which may be responsible for the differential developmental patterns 
displayed by granule neurons in cells from these morphologically similar brain areas, and the signaling 
pathways employed were also studied. Other in vitro studies were done to examine the mechanisms 
underlying glucocorticoid-induced apoptosis in the hippocampus, in particular with regard to the role of 
glutamatergic transmission.  
 
Results show that transforming growth factor β2 (TGF-β2), supported by the Smad signaling machinery, 
plays a key role in determining hippocampal cell fate by inhibiting proliferation and, in parallel, inducing 
neuronal maturation. Brain-derived neurotrophic factor (BDNF), better known for Trk receptor-mediated 
promotion of neurogenesis and differentiation, was found to exert anti-proliferative and pro-neuronal 
effects on developing hippocampal neurons by activating a MAP kinase cascade which interacted with 
the TGF-β signaling pathway. 
 
The glucocorticoid dexamethasone (DEX) was found to directly induce apoptosis in hippocampal cell 
cultures through the mediation of glucocorticoid receptors (GR); this effect could only be demonstrated if 
neuroprotective mineralcorticoid receptors (MR) were antagonized. Further, it was shown that mature, 
rather than immature, granule neurons are targeted by glucocorticoids for apoptosis.  
 
Additional experiments showed that glucocorticoid actions at least partially depend on the prevailing 
glutamatergic status. The apoptotic actions of DEX are, at least partly, mediated by NMDA and 
metabotropic glutamate receptors. Low doses of NMDA, acting via the synaptic NMDA receptor 
(NMDAR) were shown to efficiently block DEX-induced hippocampal cell death. Evidence was obtained 
to show that glucocorticoid-induced apoptosis in hippocampal cells is mediated by NMDAR as well as 
metabotropic receptors. Thus, the final outcome of glucocorticoid treatment on hippocampal cell survival 
depends on the convergence and integration of transcriptional signals and signals originating at the cell 
membrane. 
 
In conclusion, these studies have identified some of the factors and signaling pathways contributing to the 
orchestrated neurodevelopment of hippocampal, as well as cerebellar, neurons.  
 Resumo 
 
O desenvolvimento do sistema nervoso é o corolário de uma coordenação temporo-espacial de vários factores 
intrínsecos e extrínsecos, que apresentam, adicionalmente, importantes variações regionais. Neste trabalho 
dissertação foi avaliada a influência de factores extrínsecos, incluindo os glucocorticóides, neurotransmissores e 
citoquinas, nos mecanismos reguladores da neurogénese (proliferação, diferenciação e apoptose) pós-natal do 
hipocampo. Foram utilizadas culturas de neurónios hipocampais e cerebelosos para identificar factores e 
cascatas de sinalização responsáveis pelos padrões distintos de desenvolvimento das células granulares dessas 
áreas cerebrais. Foram ainda realizados estudos in vitro para analisar os mecanismos subjacentes à apoptose 
hipocampal induzida por glucocorticóides, em particular aqueles que envolvem a transmissão glutamatérgica.  
 
Os resultados obtidos demonstram que o “transforming growth factor β2” (TGF-β2), e a vias de sinalização 
Smad, desempenha um papel determinante no destino das células hipocampais porque inibe a sua proliferação 
e, em paralelo, promove a diferenciação neuronal. Ao invés, o “brain-derived neurotrophic factor” (BDNF), 
conhecido por promover neurogénese e diferenciação neuronal através de receptores tirosina cínase (Trk-r), 
revelou um efeito anti-proliferativo e favorecedor da maturação neuronal pela activação da cascata da cínase 
MAP que, por seu turno, interactua com a via de sinalização do TGF-β. 
 
Demontrou-se ainda que a dexametasona, um glucocorticóide, induzia directamente apoptose em culturas de 
células hipocampais, numa acção mediada pelos receptores dos glucocorticóides (GR); porém, este efeito era 
apenas evidente se o efeito neuroprotector dos receptores minerolocorticóides (MR) fosse concomitantemente 
bloqueado. Ficou também demonstrado que apenas as células granulares diferenciadas eram alvo da apoptose 
mediada pelos glucocorticóides.  
 
Experiências subsequentes permitiram evidenciar que as acções dos glucocorticóides dependiam, pelos menos 
parcialmente, da neurotransmissão pelo glutamato. Com efeito, a apoptose induzida pela dexametasona era em 
parte mediada pelos receptores NMDA e metabotrópicos do glutamato. Curiosamente, doses baixas de 
glutamato, activando os receptores sinápticos do NMDA, bloqueavam eficazmente esse efeito apoptótico. O 
balanço final do tratamento com glucocorticóides em células hipocampais em cultura depende, pois, da 
convergência e integração de sinais dependentes da transcrição e de outros com origem na membrana celular. 
 
Em conclusão, estes estudos permitiram a identificação de factores e vias de sinalização que contribuem para a 
complexa orquestração do desenvolvimento de células hipocampais e cerebelosas.  
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Chapter 1  
 
 
 General Introduction  
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 1.1. The life cycle of the neuron 
The neuron, the basic function unit of nervous system, is composed of a large cell body and is characterised by 
its axon and dendrites. Axons and dendrites receive and transmit information using chemical or electrical 
signals. 
 
During early development (e.g. E14 in rodents), neurons are generated as neuronal precursors from the 
asymmetrical division of stem cells located in subventricular zone of the brain (Brazel et al., 2003; Alvarez-
Buylla et al., 2000). These precursors migrate to their final position following tangential or radial pathways. 
Neuronal production continues during postntal life in several brain regions, including the olfactory bulb, 
hippocampus, cerebellum, and cortex; neurogenesis in these various regions varies in intensity (highest during 
early life) and extends over different periods, e.g. throughout life in the olfactory bulb and hippocampus, and 
for much shorter periods in the cerebellum and cortex.  
 
Despite high rates of neurogenesis during embryogenesis and early postnatal development, only a proportion of 
newly-generated cells will survive; most (70% of cortical cells in E14 mouse, Blaschke 1996) die through 
programmed cell death (apoptosis) due to inadequate neurotrophic support. The surviving cells mature and 
establish complex neurite extensions and synapses. While most neurons survive for an extended period of the 
lifespan, granule cells in the olfactory bulb and dentate gyrus of the hippocampus, continually die and undergo 
renewal from progenitor cell reservoirs.  
 
1.2. Neurodevelopmental windows 
During development, neuronal proliferation, migration, differentiation and maturation are regulated by multiple 
intra (intrinsic) and extra (extrinsic) cellular factors, which change in a temporal and spatial way. The most 
frequently cited case is that of the different cell fates of neural stem cells of different ages or anatomical 
origins. The differentiation of neurons, astrocytes and oligodendrocytes in the neocortex peaks sequentially 
before, during and after birth (Sauvageot and Stiles, 2002). The importance of positioning is illustrated by 
considering that neocortical pyramidal neurons born in the dorsal ventricular zone migrate radially to establish 
a six-layer- structure in an inside-out manner (Rakic, 1987; 1988); GABAergic neurons and oligodendrocytes 
originating in the ventral ventricular zone migrate tangentially to their final destinations (Corbin et al., 2001; 
Parnavelas, 2000; Tekki-Kessaris et al., 2001); and cerebellar Purkinje cells and hippocampal pyramidal 
neurons arise earlier than cerebellar and hippocampal granule cells (Smeyne et al., 1995; Sonmez and 
Herrup,1984; Vogel et al.,1989; Mullen et al.,1997; Altman, 1990; 1965; Harman, 1997). Also of relevance is 
the observation of GABA and GABA decarboxylase (GAD) in hippocampal granule cells and GABA in mossy 
fibers until 22-23 days of age, after which their presence is downregaulated with increasing maturity (Gutierrez 
et al., 2003). All these temporal and spatial differences are controlled by the interplay of intrinsic and extrinsic 
regulatory molecules.  
 
1.2.1. Intrinsic regulators 
The bHLH (basic helix-loop-helix) transcription factors are a large family with ~125 members encoded in the 
human genome (Ledent et al., 2002). Several of these factors have been shown to control the proliferation and 
differentiation of cortical progenitor cells (Ross et al., 2003). The transition from proliferation to initial 
neurogenesis and terminal neuronal differentiation correspond temporally with the differential expression 
 levels of bHLH factors, from decreased Hes, Id, to increased neurogenin (Ngn), Mash1 and NeuroD (Ross et 
al., 2003).  
• Hes, Id (bHLH differentiation inhibitors) and Ngn, Mash1 (bHLH proneuronal factors) are expressed 
in the ventricular zone of the telencephalon and trigger differentaition of progenitors there.  
•  NeuroD, NeuroD2, Nex (bHLH differentiation genes) are expressed in the cortical plate, where fully 
differentiated neurons are located (Ross et al., 2003).  
•  Ngns are expressed in the dorsal telencephalon and stimulate the differentiation of glutamatergic 
neurons; 
•  Mash1 is expressed in the ventral telencephalon where GABAergic and cholinergic neurons arise 
(Wilson and Rubenstein, 2000).  
•  In addition, bHLH gene products interact with other molecules (Notch1, Prox1) to delineate the 
sequential stages of dentate gyrus development (Pleasure et al., 2000).  
 
Members of the bHLH family have also shown to induce cell cycle arrest by activating cdk inhibitors (Farah et 
al., 2000), e.g. through the Cip/Kip cdk inhibitors, p21Cip1 and p27Kip1, which interact with cyclin D-cdk4/6 and 
cyclin E-cdk2 (Massague et al., 2000). In this context, it is interesting that p27Kip1 and the cell cycle 
retinoblastoma Rb protein (a cdk substrate) were detected in E14.5 progenitors but not E10.5 progenitors in the 
rat neural tube (Luo et al., 2002), indicating temporal coordination in the expression of the various cell cycle 
regulator molecules. Indeed, temporal patterns of expression of neurogenesis-regulating genes can be 
evolutionarily traced back to Drosophila in which competence to acquire early-born fates is restricted to 
mitotic neuronal precursors; in this species, the Hunchback gene causes neuroblasts to gradually lose their 
competence to generate early-born cell types (Pearson and Doe, 2003).  
 
1.2.2. Extrinsic regulators 
Heterochronic transplants in the ferret cortex showed that transplanted young progenitor cells can adopt the cell 
fate of the recipient environment, whereas older progenitor donor cells cannot take up the features of a younger 
recipient; the latter progenitors continue to express characteristics which correspond to their age (Desai and 
McConnell, 2000), thus implicating a role for regulatory factors in the extracellular environment.  
• The transforming growth factor-β (TGF-β) superfamily which consists of more than 35 members, 
including TGFβ1 and 2, the bone morphogenetic proteins (BMPs), growth differentiation factors 
(GDFs), activins, glial cell line-derived neurotrophic factor (GDNF), represents a large group of 
extracellular growth factors that display wide distribution. The functions of members of this 
superfamily include cell cycle control and differentiation during neural development (Bottner et al., 
2000). For example, TGF-β2 was reported to stimulate (Mahanthappa and Schwarting 1993) or inhibit 
(Constam et al., 1994) neurogenesis, or both (Kane et al., 1996), as well as to regulate neuronal 
differentiation (Ishihara et al., 1994; Abe et al., 1996; Cameron et al., 1998). TGF-β2 is expressed in a 
temporal and spatial pattern during development. TGF-β2 levels peak in cerebellar granule cells at 
postnatal day 10 while these cells are proliferating and migrating; thereafter, their levels decline and 
they are only expressed in adult cerebellar Purkinje cells (Constam et al., 1994; Unsicker and Strelau, 
2000). TGF-β2 immunoreactivity is seen not in the ventricular zone, but is present in the subventricular 
zone, the telencephalic cortex and the cerebellar anlage of the E16 rat (Flanders et al., 1991). Together, 
these observations suggest that TGF-β2 contributes to neuronal differentiation.  
• In contrast to TGF, the BMP signals block neural maturation and promote an epidermal fate; 
consistently, BMP mRNA is expressed in epidermal, but not neural cells (Wilson and Edlund 2001). 
Interestingly, the temporal and spatial patterns of expression of BMPs during mouse embryonic 
development correspond with its role as a proliferation inhibitor and stimulator of apoptosis in the 
dorsomedial telencephalon (Furuta et al., 1997). BMP exert both positive and negative effects on 
 neurogenesis, depending on ligand identity, ligand concentration and the lineage of the responding cell 
(Furuta et al., 1997; Shou et al., 2000; Zhu, et al., 1999; Mabie et al., 1999; Angley et al., 2003). 
Expression of both BMP2 and its receptors is highest during embryonic development, with a sharp 
decline during postnatal life (Mehler et al., 1997). 
• Expression of GDNF and its receptors (Widenfalk 1997; Koo 2001) show distinct spatial and temporal 
patterns. Pinna Serra (2002) demonstrated that GDNF-like immunoreactivity in the neonatal human 
hippocampus is much higher than in the adult hippocampus. The GDNF receptor C-ret is highly 
expressed in the dorsal pyramidal cell layer of the hippocampus at P4-P7, declining markedly 
thereafter. The GDNF receptor GFR-α2 shows a similar expression profile in the cerebellar granule cell 
layer (Burazin, 1999). GDNF, plays a crucial role in the differentiation, proliferation and survival of 
neurons, by acting through GFR and RET receptors (Airaksinen and Saarma, 2002). GDNF mRNA and 
protein levels in the hippocampus increase from early embryonic age to birth, reaching a peak during 
the first postnatal week and declining to prenatal levels in the adult (Ikeda et al.,1999; Lenhard and 
Suter-Crazzolara, 1998). The mRNA for its receptors are expressed at higher levels in adult 
hippocampal granule cells than in adult cerebellar granule cells (Burazin and Gundlach,1999). 
• GDF10 mRNA expression in rodent brain was observed in the cingulate cortex, retrosplenial cortex, 
CA3 and ventral limb of the dentate gyrus at P6, persisting in the cingulate cortex up to P21; in marked 
contrast, GDF10 expression continues to be seen in the hippocampal granule and caudal CA3 cells well 
into adulthood (Soderstrom and Ebendal 1999). 
• Members of the neurotrophin family (e.g. brain-derived neurotrophic factor [BDNF] and nerve growth 
factor [NGF]) are also representative of extrinsic factors whose distribution follows spatial and 
temporal patterns; the role of these molecules in the control of neuronal survival, proliferation, and 
differentiation are well documented. Levels of most neurotrophins increase during ontogeny of the 
brain, peak around birth and decline in adulthood. They usually show region-specific patterns of 
distribution, although they may overlap in some areas or at particular stages of development (Rocamora 
et al., 1993; Zhou et al., 1994). 
 
1.2.3. Lifetime events 
The birth, maturation and survival of neurons are also heavily under the influence of lifetime events. These 
may include physiological and cellular stressors, social status, agressivity (Mirescu et al., 2004), nutrition, 
exercise, pharmacological treatments (Dekosky et al., 1982; Yu et al., 2004; Deisseroth et al., 2004), etc. The 
ultimate effects of the above factors will be determined by the variety of extrinsic and intrinsic factors 
described above as well as other endocrine, paracrine and autocrine factors; some of these are summarized in 
the following Tables.  
 
Regulators of Neuronal Birth – some examples* 
Factors Effects System 
FGF family +proliferation  +/-Neurogenesis P0 rat HP,CB; adult SVZ 
  Dissociated embryonic rat RT,CTX,HP,ST,SPC; adult 
SVZ,HP 
   
EGF family   
TGF-α +proliferation  +/-Neurogenesis Adult rat DG 
EGF +proliferation  +/-Neurogenesis Dissociated rat ST,HP,OE; adult SVZ 
GGF +proliferation   Dissociated NCSC 
   
TGFβ family   
TGFβ2 -/+proliferation  +/-Neurogenesis Embryonic rat OE, CB; Dissociated CB granule cell 
precursors 
TGFβ3 +proliferation +Neurogenesis Embryonic rat RT 
BMP2,4,5,6,7 -proliferation +-Neurogenesis Dissociated rat NCSC, SVZ, embryonic SPC explants 
 GDF11 -proliferation  +Neurogenesis Rat OB 
GDNF +/-proliferation  +Neurogenesis NT2/D1,SH-SY5Y, C6; Dissociated rat 
photoreceptors, NCSC, mouse progenitors 
Neurotrophins  
NGF +proliferation  +Neurogenesis PC12, rat chromaffin cell, DRG, chick sympathetic 
ganglia embryo 
BDNF +/-proliferation  +Neurogenesis Dissociated rat HP; SVZ; CB granule cell,  
NT-3 +proliferation  +Neurogenesis Rat DRG, NCSC, sympathetic neuron 
NT-4/5 +Neurogenesis CB granule cell 
IGF-1 +proliferation  +Neurogenesis CB granule cell precursors, NSC 
CNTF/LIF +/-Neurogenesis Dissociated fetal/adult rat stem cells 
Table continued on next page – 
 
  
PDGF +proliferation  +Neurogenesis Rat NSC 
Hormones   
Thyroid hormones, retinoic 
acid 
+Neurogenesis Dissociated rat photoreceptors 
Glucocorticoids -proliferation  +Neurogenesis Rat hippocampal cells in vitro; 
Mineralocorticoids +proliferation Hippocampal cells in adrenalectomized rat  
Estrogens -proliferation  +Neurogenesis Mouse embryonic stem cells 
   
Excitatory amino acids   
Non-NMDAR agonist 
(kainite) 
-proliferation E16/E18 rat CTX explants 
NMDAR agonist (NMDA) -proliferation Adult rat DG 
NMDAR antagonist 
(MK801) 
+proliferation P2-5 and adult rat DG 
   
Inhibitory amino acids   
GABA -proliferation E16/18 dissociated rat CTX, explants 
 +proliferation P6-8 rat CB granule cell precursors; E13-14 mouse VZ 
Biogenic amines  
-Monoamines (αMPT, 
reserpine) 
-proliferation P11 SVZ 
-serotonin synthesis 
inhibitor (pCPA) 
-proliferation E8-12 SC and HP 
Cholinergic agonist 
(nicotine) 
-proliferation Embryonic or postnatal CTX 
   
Neuropeptides   
Opioids   
Met5-enkephalin -proliferation P6 rat CB 
Opioid R antagonist 
(naltrexone) 
+proliferation P6 rat CB, DG, SVZ 
VIP/PACAP   
PACAP  -proliferation E13.5 rat dissociated CTX 
VIP +proliferation E15.5 rat dissociated SCG 
VIP antagonist -proliferation E6 mouse prosencephalon 
   
Tumour suppressors   
RB -proliferation Rat SVZ, HP subgranular progenitors 
PTEN -proliferation Mouse NSC, 
SHH +proliferation Rat adult HP progenitors, CB granule cell precursors; 
mouse retinal precursors 
WNT +/-proliferation, +neurogenesis Mouse NPCs, SVZ progenitors, midbrain precursors 
* Based on Cameron HA, Hazel TG & McKay RDG (1998) J Neurobiol 36: 287-306. 
BDNF, brain derived neurotrophic factor; BMP, bone mophogenetic protein; CB, cerebellum; CNTF, ciliary neurotrophic 
factor; CTX, cortex; DG, dentate gyrus; EGF, epidermal growth factor; ESC, embryonic stem cells; FGF, fibroblast growth 
factor; GABA, gamma aminobutyric acid; GDF, growth/differentiation factor; GDNF, glia derived neurotrophic factor; HP, 
hippocampus; IGF-1, insulin like growth factor-1; LIF, leukemia inhibitory factor; NCSC, neural crest stem cells; NGF, 
nerve growth factor; NMDA, N-methyl D-aspartate; NPC, neural procursor cells; NSC, neural stem cells; NT, neurotrohpin; 
OE, olfactory epithelium; PACAP, pituitary adenylate cyclase activating peptide; PDGF, platelet derived growth factor; 
PTEN, phosphatase and tensin homolog deleted on chromosome 10; RT, retina; SC, superior colliculus; SCG, superior 
cervival ganglion; SHH, sonic hedgehog; SPC, spinal cord; ST, striatum; SVZ, subventricular zone; TGF, transforming 
growth factor; VIP, vasoactive intestinal peptide. +, stimulation; -, inhibition. 
 
  
Regulators of Neuronal Death – some examples  
Factors Functions 
Death ligands  
Fas Bind Fas-L, by recruiting FADD, activate caspase-8, and begin caspase cascade to apoptosis 
TNF Bind TNF receptors, the activation of death domain lead to apoptosis by JNK or caspase pathway  
  
TGFβ superfamily  
TGFβ1 Protect neuron from apoptosis via c-jun-AP1 pathway 
GDNF Promote neuronal survival 
  
Neurotrophins  
NGF Promote neuronal survival 
BDNF Promote neuronal survival 
NT-3 Promote neuronal survival 
NT-4/5 Promote neuronal survival 
  
Excitatory amino acids  
NMDA Activate NMDA-R, induce calcium influx and apoptosis cascades 
Kainite Activate GluR5-7, KA1,2, induce sodium influx and cell swelling 
AMPA Activate GluR1-4, induce sodium influx and cell swelling 
  
Hormones  
Glucocorticoids  
Corticosterone Activate MR and GR, low level is neuroprotective  
Dexamethasone Activate GR, induce apoptosis in HP granule cells  
Tumour suppressors*  
RB Promote cell cycle arrest, apoptosis 
PTEN Block Akt activity of phosphorylating Bad, pro-apoptotic 
P53 G1 phase cell cycle arrest, apoptosis 
P53BP1 Responding to DNA-double-strand breaks 
SMC1 Intra-S-phase checkpoint; chromosome integrity and the prevention of DNA-damage hypersensitivity 
NBS1 Responding to DNA-double-strand breaks; S-phase-cell cycle arrest 
MDM2 P53 protein regulation 
FANCD2 Intra-S-phase checkpoint 
CHK2 Cell cycle arrest, apoptosis and signaling to p53 
CTIP Regulates BRVA1 function 
BRCA1 Homologous recombination repair 
ATM Autophosphorylation and self activation; coordinating the responses to DNA double-strand breaks 
  
Apoptosis-related 
proteins 
 
Bcl2, Bcl-XL Inhibit apoptosis by preventing the release of AIF and cytochrome c from mitochondria 
Bad Pro-apoptotic, Dephosphorylation of Bad cause the release of cytochrome c from mitochondria 
Bax, Bak Pro-apoptotic, promote mitochondria permeability  
AIF Apoptosis inducing factor, induce nuclear condensation and large scale DNA fragmentation in a caspase-
independent fasion 
Caspases Release of cytochrome c from mitochondria and formation of cytochrome c/Apaf-1/caspase-9 complex 
initiate caspases activation, cleave downstream substrates and lead to DNA ladder. 
  
Transcription factors  
NFκB Inhibit apoptosis 
IκB Inhibit NFκB 
* Taken from: Baker SJ & McKinnon PJ (2004) Nature Reviews Cancer 4: 184-195. 
AMPA, Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF, brain derived neurotrophic factor; GDNF, glia derived neurotrophic 
factor; NGF, nerve growth factor; NMDA, N-methyl D-aspartate; NT, neurotrohpin; PTEN, phosphatase and tensin homolog deleted on 
chromosome 10; TGF, transforming growth factor; TNF, tumor necrosis factor.   
 1.3. Structure, neurochemistry and function of the hippocampus 
The hippocampal formation comprises the entorhinal cortex, hippocampus proper, dentate gyrus and subicular 
complex. The hippocampal formation is an arched or banana-shaped structure, symmetrically located besides 
the inferior horn of lateral ventrical in the posterior of the dorsal lateral part of the telencephalon, with its long 
axis extending from the septal nuclei rostro-dorsally to the temporal lobe caudoventrally. The hippocampus 
proper is composed of the polymorphic layer (hilus), the pyramidal cell layers and the molecular layer (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of hippocampus by Golgi, using his silver impregnation stain.  
 
The pyramidal cell layer is divided into the CA1, CA2, CA3 regions, according to differences in cellular 
architecture: the CA1 region contains small pyramidal neurons while the CA2 and CA3 regions contain larger 
neurons; the dentate gyrus includes the polymorphic layer and the granular and molecular layers. The granular 
layer is composed of tightly packed granule neurons, which send mossy fibers to CA3 pyramidal cells. The 
granule cells receive inputs from the entorhinal cortex via the perforant pathway, and the CA3 neurons project 
to CA1 neurons via the Shaeffer collateral pathway. Most of the afferent pathways within the hippocampus 
appear to be glutamatergic, although the hilar-granule connections are mainly GABAergic. Besides perforant 
pathway, the dentate gyrus also receives cholinergic and GABAergic inputs from the septal nuclei, 
noradrenergic input from the locus coeruleus, serotonergic input from the raphe nuclei and dopaminergic input 
from the ventral tegmental area. In addition, the hippocampus expresses several neuropeptides and many of its 
cells are rich in calcium binding proteins.  (Amaral and Witter, 1995; Freund and Buzsaki, 1996)  
 
Together, the inter-connected regions of the hippocampal formation form part of the so-called ‘Papez circuit’, 
named after James Papez who proposed a model of interacting brain regions to explain the conscious (cortical-
mediated) and peripheral manifestations (hypothalmic- mediated) aspects of emotion (Papez, 1937). This basic 
plan gave rise to the denomination limbic system, introduced by Paul MacLean who added the following 
structures: the orbitofrontal and medialfrontal cortices (prefrontal area), the parahippocampal gyrus and 
important subcortical groupings like the amygdala, the medial thalamic nucleus, the septal area, prosencephalic 
basal nuclei (the most anterior area of the brain) and a few brainstem formations (MacLean, 1949) (see Fig. 2) 
CA1 
CA2 
CA3 
DG 
hilus 
  
 
Figure 2. Schematic representation of Papez’ circuit, consisiting of the cingulate gyrus, anterior thalamjic 
nuclei, mammiliary bodies and hypothalamus and the hippocampal formation; some of the other structures 
added to this circuit by MacLean include the prefrontal and associative cortices and the amygdala.  
 
Recently, Lein, E.S. et al. (2004) and Zhao, X. et al. (2001) produced what may be called a ‘molecular atlas of 
the hippocampus’, based on results obtained by DNA microarray analysis and in situ hybridization 
histochemistry. These authors found certain relationships between the intensity of gene expression and cell 
morphology. For example, they found that the expression of the nephroblastoma-overexpressed gene (Nov) is 
restricted to the CA1 pyramidal layer, the Purkinje cell protein 4 gene is restricted to the CA2 and dentate 
gyrus, and bcl-2 related ovarian killer protein gene is restricted to the CA3 region. In addition, desmoplakin 
expression was restricted to dentate granule cells, while that of calretinin was confined to hilar cells and cells 
within the subgranular zone of the dentate gyrus, and Mrg1b to CA1-CA3 pyramidal cells. 
 
The hippocampus is best known for its role in learning and memory. Evidence for its role in cognition includes 
experiments showing that damage to the hippocampus leads to severe impairment of declarative (explicit, 
relational) memory (Squire, 1992). Also, blockade of NMDA receptors and prevention of LTP impair learning 
of new spatial tasks (Morris, 1989).  
 
 The hippocampus also functions as a site of corticosteroid negative feedback, therefore contributing to the 
neural regulation of the hypothalamic-pituitary-adrenocortical (HPA) axis. Loss of hippocampal neurons or 
reductions in the levels of glucocorticoid receptor [GR] expression lead to hypercortisolism and DEX 
resistance, while stimulation of the hippocampus inhibits GC secretion (Sapolsky and Plostsky, 1990). Besides 
GR, the hippocampus in fact contains another type of corticosteroid receptor, namely, the mineralocorticoid 
receptor (MR). It is believed that while GR mediate negative feedback signals, MR mediate inhibitory tone on 
HPA axis activity (Reul et al., 2000).  
 
Lastly, one aspect of hippocampal structure should be mentioned. While the pyramidal cell layers are already 
formed and post-mitotic at the time of birth, granule cells in the dentate gyrus form just before birth (in the rat), 
and in all species thus far examined, continue to proliferate throughout life (Kempermann et al., 2004; Arlotta 
et al., 2003; Seki et al., 2003; Gage et al., 1998).  Newly generated granule cells in the adult animal were 
shown to facilitate synaptic plasticity, thereby contributing to the formation of new memories (Schmidt-Hieber 
et al., 2004). A number of external enviromental factors, including physical activity, stress and learning 
influence hippocampal neurogenesis (Prickaerts et al., 2004); stress, for example inhibits proliferation of 
progenitor cells and has been suggested to be one of the underlying pathophysiological mechanisms of major 
depression (a condition accompanied by hyperactivity of the HPA axis). Interestingly, anti-depressant drugs 
stimulate the production of new granule neurons and the latter has been suggested to underpin the therapeutic 
actions of these drugs (Malberg, 2004; Santarelli et al., 2003). 
 
1.4. Neurodevelopmental similarities between the hippocampus and cerebellum  
Hippocampal and cerebellar granule cell formation begins towards the end of the embryonic period, with the 
majority of cells being born during the first postnatal week in rats (Altman et al., 1965, 1972, 1990, 
Schlessinger et al., 1975). The newly-born cells are formed from precursor cell populations in the secondary 
germinal matrix (external granular layer, EGL, in the cerebellum; hilus in the hippocampus) which migrate to 
the proliferative zone without the aid of radial glial guides (Tomasiewicz et al., 1993; Corbin et al., 2001), 
eventually forming a tightly-packed cellular layer in a phylogenetically ancient cortical structure of the brain 
(Altman, 1969). While hippocampal granule cell proliferation continues throughout life, albeit at a reduced rate 
as the organism ages (Kuhn et al., 1996; Cameron & McKay, 2001), cerebellar granule cell production ceases 
when the EGL disappears during early postnatal life (Altman et al., 1965, 1972, 1990, Schlessinger et al., 
1975). 
 
Granule neurons are characterized by highly condensed chromatin and little cytoplasm (Palay & Chan-Palay, 
1974, Laatsch & Cowan, 1966, Romon y Cajal, 1911), and express GABA receptors (Tietz et al., 1999, Kim et 
al., 2000) and glutamate receptors (Wisden et al., 2000, Shigemoto & Mizuno 2000), as well as receptors for 
other neurotransmitters, neurotrophins and growth factors (see references under the table below). On the other 
hand, hippocampal and granule cells show some distinct differences; for example, only hippocampal granule 
cells express the NR2B subunit of the glutamate receptor whereas the NR2C subunit of this receptor are found 
in their cerebellar counterparts (Wisden et al., 2000). Also, during early development, cancer-related genes are 
more active in cerebellar granule cells but not in their hippocampal counterparts (Saito et al., 2002). The Table 
below shows some distinstive and common features of hippocampal and granule neurons. 
 
 
 
  
 
 
 
Comparison of Cerebellar & Hippocampal Granule Cells 
 Cerebellar granule cells Hippocampual granule cells 
Derivation Metencephalon(1-4) Telencephalon(5) 
Genesis Begins at the end of embryonic 
period, reaching a peak during the 
first postnatal week of life and then 
stops when EGL disappears (6) 
Begins at the end of embryonic period, reaching 
a peak during the first postnatal week of life; 
gradually decreases but occurs at low level in 
adults also (7-9) 
Migration Migrate from secondary germinal 
matrix (EGL) as a precursor 
population in the absence of radial 
glial guides (10) 
Migrate from secondary germinal matrix (hilar 
region) as a precursor population in the absence 
of radial glial guides (11) 
Morphology 
 
5-6 µm in diameter, with cytoplasmic 
indentations in nucleus, highly 
condensed chromatin, small 
cytoplasm(12 ) 
7-10 µm in diameter, nuclear envelope rarely 
indented, highly condensed chromatin, small 
cytoplasm (13, 14) 
Architecture Tightly packed cellular layer in a 
phylogenetically ancient cortical 
structure of the brain(15) 
Tightly packed cellular layer in a 
phylogenetically ancient cortical structure of 
the brain(15) 
Glucocorticoids receptors 
 
GR+, MR+ (GR develop later than 
MR)(16) 
GR+, MR+ (GR develop at the same time as 
MR)(17) 
Ionotropic glutamate receptor 
MRNAs(18) 
NMDA receptor mRNAs (NR2B 
switches to NR2C ~ P7) 
NR1+++ 
NR2A+ 
NR2B- 
NR2C+++ 
NR2D- 
KA1- 
KA2+++ 
(KA) GluR5- 
(KA) GluR6+++ 
(KA) GluR7- 
(AMPA)GluR1- 
(AMPA) GluR2+++ 
(AMPA) GluR3- 
(AMPA) GluR4++ 
(NR2A and NR2B but not NR2C mRNAs 
expressed ) 
NR1+++ 
NR2A+++ 
NR2B+++ 
NR2C- 
NR2D- 
KA1+++ 
KA2+++ 
(KA) GluR5- 
(KA) GluR6++ 
(KA) GluR7++ 
(AMPA) GluR1+++ 
(AMPA) GluR2+++ 
(AMPA) GluR3+++ 
(AMPA) GluR4+++ 
Metabotropic glutamate receptor 
mRNAs(19) 
MGluR1+ 
mGluR2- 
mGluR3- 
mGluR4+++ 
mGluR5- 
mGluR7- 
mGluR1++ 
mGluR2++ 
mGluR3++ 
mGluR4+ 
mGluR5++ 
mGluR7++ 
Glutamate transporters(20) EAAT1- 
EAAT3+ 
EAAT1- 
EAAT3+ 
Glutaminase(21) + + 
Glycine receptor(22,23,24) + + 
GABAA receptor mRNA(25,26,27) 
 
α1++ 
α2- 
α4- 
α5- 
α6 + 
β1-+ 
β2++ 
β3+ 
γ2+ 
δ+ 
α1+ 
α2++ 
α4++ 
α5+ 
α6 – 
β1++ 
β2+ 
β3++ 
γ2+ 
δ- 
5HT receptors(28,29) Barely detectable + 
Cholinergic receptors 
(Nicotine)(30,31) 
α3+ (low level) 
α4+ (low level) 
β2+ (low level) 
+ 
Cholinergic receptors (Muscarine)(32) M2+ M1+ 
- Table continued on next page – 
 
  
PKC(33,34) β,α,ε,δ subunits+ 
(β predominates) 
ε,β,α+ 
(ε predominates) 
Calbindin(35,36) 
 
- + 
Dynorphin(37-40) - + 
Transcription factor RU49(41) 
(special marker for granule cell) 
+ + 
NeuroD (critical for granule cell 
differentiation)(42,43) 
+ (expression peaks later than in 
hippocampus) 
+ (expression peaks earlier than in cerebellum) 
Cancer related gene expression(44) More active at earlier stages No such tendency 
Interleukin 1 beta(45) + + 
NGF & Receptor gp75(45-47) + + 
BDNF & Receptor TrkB(47-49) + higher than NGF 
Stimulate migration in vivo 
+ higher than NGF 
NT-3 & Receptor TrkC(48,50-52) + + 
NT-4/5(53,54) + protects against adrenalectomy-induced 
apoptosis of rat hippocampal granule cells 
GDNF & Receptor(55-58) + + 
CNTF & Receptor(59-62) + ++ 
AFGF & Receptor(63,64) + + 
- Table continued on next page – 
BFGF & Receptor(65,67) + + 
SCG10 [growth-associated proteins 
(nGAPs) (68-70) 
 + 
GAP43 [growth-associated proteins 
(nGAPs) ](69-71) 
+ -(in adult rat) 
+(in monkey) 
Neuregulins (NRG) [glial growth 
factor (GGF), acetylcholine-receptor-
inducing activity (ARIA), heregulin 
(HRG) and neu differentiation factor 
(NDF)] &  ErB receptors 
NRG induced NR2C subunit 
expression  
ErbB2, ErbB3 and ErbB4 +(72-75) 
 
 
Pituitary adenylate cyclase-activating 
polypeptide (PACAP) 
&Receptors(76-78) 
Actively expressed in rat 
cerebellum during postnatal 
development, peaks between P4-
P20; administration of PACAP to 
P8 rats increases the number of 
surviving granule cells in the EGL 
and IGL of the cerebellum, and 
stimulates neuronal migration from 
the EGL to the IGL 
PAC(1)-R expression is maintained in adult  
 
Polysialylated form of neural cell 
adhesion molecule (PSA-NCAM) (79-
84) 
Granule cells express E-N-CAM on 
cell bodies, axons, and leading and 
trailing processes also during 
migration but cease to reveal 
detectable levels of E-N-CAM at the 
end of migration after reaching 
their final position in the internal 
granular layer 
Highly expressed during development and 
persistent expression in the adult rat 
 
Bcl-2 mRNA(85, 86) + (higher in late prenatal development 
than in postnatal and adult brain) 
+ (higher in late prenatal development than in 
postnatal and adult brain) 
CREB(87-89) + + Increased cell proliferation is accompanied 
by activation of CREB phosphorylation in 
dentate gyrus granule cells 
Nuclear factor-kappaB (NF-kappaB), 
key regulators of either cell death or 
survival in neuronal cells (90-93) 
high in granule cells before 
postnatal day 7 (P7) and declines 
after P7 
+ 
TGF-beta2 (90,94) Transient production by postnatal 
cerebellar  
4-fold up-regulation in P12 versus 
P4 cerebella, represses NF-kappaB 
activity 
+ 
- Table continued on next page 
  
Glucocorticoid treatment(95-101) • bFGF↑  
• No deficits in rotarod 
performance with Dex treatment 
• Neonataes treated with 
hydrocortisone results in 
decrease cell proliferation and 
premature cessation of 
precursors in EGL 
• Chronic corticosterone 
administration does not 
change Calbindin-D28k mRNA 
and protein levels 
• Decrease GR,MR 
• NGF mRNA ↑, bFGF↑ 
• Deficits in Morris water maze 
performance with Dex treatment 
• 2 months rat treated with corticosterone 
for 3hrs decreased cell proliferation 
 
 
• Chronic corticosterone administration 
increased Calbindin-D28k mRNA and 
protein levels 
• Decrease GR,MR 
Adrenalectomy(99,102-107) • P11 ADX enhances cell 
proliferation and delays 
disappearance of EGL 
• P22 ADX decreases glutamine, 
glutamine synthetase, with 
taurine, aspartic, glutamic and 
GABA unchanged 
• 3 months ADX has no effect on 
Calbindin-D28k mRNA and 
protein levels in rats 
• Increase GR,MR 
• P11 ADX enhances cell proliferation  
• P22 ADX decreases glutamine, glutamine 
synthetase, with taurine, aspartic, glutamic 
and GABA unchanged 
• 3 months ADX decreases Calbindin-D28k 
mRNA and protein levels in rats 
• 2 months ADX increases cell proliferation 
in rats 
• 3 months ADX induced granule cell loss 
• Increase GR,MR 
Transplantation(108-110) • Neonate cerebellar granule cells 
switch calbindin gene on when 
transplanted into neonate 
hippocampus 
• Gestation day 14 (E14) 
cerebellar primordium 
transplanted into adult rat 
cerebellum, expression of 
tenascin, BDNF and NGF-R 
found during migration and 
differentiation of grafted 
Purkinje and granule cells  
Adult rat hippocampal progenitors did not 
express neuronal markers after being 
transplanted into the adult cerebellum for 8 
weeks 
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1.5. Problems addressed in this thesis 
The questions addressed here may be placed in three major categories:  
¾ Factors contributing to differential neurodevelopmental patterns 
Cerebellum-hippocampus transplantation experiments have suggested the importance of factors released 
by the donor and/or host cells in neurogenesis (Yoshimura et al., 2000; Tao et al., 1997; Borghesani et al., 
2002) and cell fate decisions (Renfranz et al., 1991; Vicario-Abejón, 1995; Suhonen et al., 1996; Alder et 
al., 1999). Little is known about the identity of the intrinsic and environmental signals that maintain the 
equilibrium between neuronal birth, maturation and death. Whereas some factors (e.g. bFGF, PDGF) 
mainly function as promoters of proliferation, others (e.g. TGFβ, BMP, GDF, GDNF) act as inhibitors of 
proliferation. Like the neurotrophins (e.g. BDNF, NGF), factors such as IGF-1 and GDNF enhance 
neuronogenesis, whereas factors such as LIF, BMP and CNTF stimulate astrogenesis. In one part of this 
thesis, we attempted to identify the factors that may be involved in the differential timing of neurogenesis 
in the cerebelum vs. the hippocampus, focussing on the question of whether each brain region may be 
characterized by specific anti-proliferative and differentiating factors which come into play within 
 different windows of time. Earlier studies suggested that autocrine or paracrine secretions may play a role 
in the proliferation, survival and differentiation of developing granule neurons (Gao et al., 1991; Ueki et 
al., 2003), with a number of experimental paradigms indicating regulatory roles for the neurotrophin 
BDNF (Lin et al., 1998; Borghesani et al., 2002) and other cytokines (bFGF: Tao et al., 1997; members 
of the TGFβ superfamily: Unsicker and Strelau, 2000; Pratt and McPherson, 1997; Alder et al., 1999; 
Angley et al., 2003) in these events. Mumm et al., (1996) demonstrated autoregulation of neurogenesis 
and, more recently, Wu et al., (2003) showed that mature neurons in the olfactory epithelium secrete a 
factor (GDF11) that negatively regulates the proliferation of progenitor cells. These questions  were 
addressed using in vitro systms and are described in Chapter 2.  
¾ Mechanisms of glucocorticoid-mediated apoptosis in the hippocampus 
Glucocorticoids are hormones secreted from adrenal cortex, part of the HPA axis. Corticosterone (in 
rodents) or cortisol (in humans), by activating GR and MR, play an important role in development and 
physiological activity. Both receptors are expressed in hippocampus, and granule cell survival and 
apoptosis are balanced by the activation of these two receptors: MR activated by low coticosterone levels 
appear to mediate neuroprotective actions, whereas GR which are activated by high corticosterone levels 
lead to apoptosis of hippocampal granule cells (Almeida et al., 2000). Previous studies showing that the 
synthetic GR agonist dexamethasone (DEX) can induce granule cell death (Hassan et al., 1996; Almeida et 
al., 2000) raised interpretational questions requiring demonstration that DEX can directly target 
hippocampal neurons for death. Chapter 3 describes the results of experiments designed to solve this 
question using primary hippocampal cell cultures. The presented results also confirm the view that, 
because of their neuroprotective properties, activated MR can counteract the cell death-inducing actions of 
GR.  
¾ Endocrine (adrenal)-neurotransmitter (EAA) interactions 
Glutamate is the dominant neurotransmitter in the brain, being found in most excitatory synapses. Its 
actions are mediated by ionotropic glutamate receptors (iGluR) and metabotropic glutamate receptors 
(mGluR). The iGluR are directly associated with ligand-gated ionophores permitting Ca2+ influx, whereas 
the mGluR are G protein-coupled receptors which can activate secondary messengers such as cAMP or 
diacylglycerol and phosphoinositides (Lipton and Rosenberg, 1994; Pin and Duvoisin, 1995). Both types 
of receptor can activate downstream pathways that determine cell survival or death. Their dichotomous 
actions appear to result from differences in the duration and magnitude of action and the subsequent levels 
of intracellular Ca2+; thus, synaptic NMDA receptors (NMDA.R) have been associated with the promotion 
of cell survival and extrasynaptic NMDA.R with apoptosis (Hardingham et al., 2002; Riccio and Ginty, 
2002).               
Glucocorticoids and GluR share an intimate relationship: (i) glucocorticoids can increase hippocampal cell 
vulnerability to glutamate receptor (GluR) activation (Armanini et al., 1990); (ii) GR activation leads to an 
upregulation of the expression of one type of GluR, the ionotropic NMDA receptor (NMDA.R), which is 
strongly implicated in neurotoxicity (Weiland et al., 1997); (iii) GR occupation has been associated with 
an increase in glutamatergic transmission (Moghaddam et al., 1994) and (iv) glutamate can enhance GR 
activation (Gursoy et al., 2001).  In light of these interactions, and given the neurotoxic potential of each, 
glutamate and glucocorticoids, the many possibilities for mutual potentiation of each other’s effects, 
experiments were conducted to explore the mechanisms through which glucocorticoids can modulate 
glutamatergic effects on hippocampal cell death and survival. The results of these studies are presented in 
 Chapters 4 and 5; the latter chapter also addresses the question of whether immature or mature neurons are 
targeted by glucocorticoids and glutamate. 
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 2.1. Supplementary background information 
The neurotrophin family, whose main members are NGF, BDNF, NT3, NT4/5, play proliferation-, growth- and 
survival-promoting functions in the central and peripheral nervous systems. These peptide ligands bind to their 
corresponding tyrosine kinase (Trk) receptors: NGF to TrkA, BDNF to TrkB, NT3 to TrkC, and NT4/5 to TrkB 
receptors. In turn, the Trk receptors activate downsdream Ras-Raf-MEK-ERK pathways, ultimately influencing 
the above-mentioned developmental processes, as well as neuronal differentiation and synapse formation and 
activity.   
 
The TGF-β superfamily is a large family (> 30 members, including TGF-β2, activin, Nodal, and BMP, GDF) 
of peptides which exert important actions throughout a neuron’s life (proliferation, differentiation and 
apoptosis). Members of the TGF-β superfamily signal by sequentially binding to two transmembrane protein 
serine/threonine kinases; ligand binding to type II receptors activates type I receptors. Receptor-regulated 
SMAD proteins (R-SMAD) serve as substrates of type I receptors which subsequently bind Co-Smad4 and 
translocate to the nucleus, forming a transcriptionally-active complex after association with DNA-binding 
partner(s). This last complex binds to promoter elements of target genes whose functions include regulation of 
the cell cycle, differentiation and cell adhesion, positioning, and movement (Moustakas et al., 2001; Chang et 
al., 2002; Shi and Massagué, 2003). Cross talk between the TGF-β pathway and other signaling pathways are 
now known, even if incompletely understood. For example, the extracellular receptor kinase (ERK) can 
phosphorylate some of the Smads. In addition, TGF-β can signal independently of the Smads by activating 
mitogen-activated protein kinases (MAPKs) such as ERK1/2, p38 and the c-Jun-N-terminal kinase JNK, by 
activating upstream kinase activators (Attisano and Wrana, 2002). 
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 Abstract 
Hippocampal and cerebellar granule cells share several similarities, but while hippocampal granule cells self-
renew throughout life, their cerebellar counterparts become post-mitotic during early post-natal development. 
Here, we show that locally-acting, tissue-specific factors determine the proliferative potential of these two cell 
types. Thus, conditioned medium from hippocampal cells (CMHippocampus) stimulates proliferation in cerebellar 
cultures (measured by bromodeoxyuridine incorporation) and, vice versa, mitosis in hippocampal cells is 
inhibited by CMCerebellum in a dose- and time-dependent manner. The anti-proliferative effects of CMCerebellum 
were associated with an increase in the expression of the cyclin-dependent kinase inhibitors p21 and p27 as 
well as markers of neuronal maturity/differentiation. Boiling CMCerebellum resulted in a loss of anti-proliferative 
activity, indicating its peptidergic or protein nature. Fractionation of CMCerebellum using ion exchange 
chromatography yielded fractions with distinct antiproliferative/differentiating and neuroprotective activities. 
Preadsorption of CMCerebellum with antisera against candidate cytokines indicated that TGF-β2 and BDNF 
contribute to the anti-proliferative and pro-differentiating effects of CMCerebellum, an interpretation strengthened 
by the reproducibility of CMCerebellum effects with exogenous TGF-β2 and BDNF. CMCerebellum was shown to 
enhance nuclear translocation of Smad 2 (transducer of TGF-β2 signaling) and Co-Smad 4. Transient 
expression of dominant negative forms of Smad 3 and Smad 4 (acting downstream of TGF-β2 specifically) 
negated the anti-proliferative/differentiating actions of CMCerebellum. BDNF was shown to activate the 
MEK/ERK pathway, perhaps subsequently TGF-β2 signaling mechanisms. In conclusion, hippocampal 
neuronal proliferation and differentiation are regulated through an interplay between the paracrine actions of 
BDNF and TGF-β2. 
 Introduction  
Control of cell fate, including the mechanisms governing cell proliferation, differentiation and death, is a 
central theme in developmental neurobiology. Besides contributing to a better understanding of these biological 
processes, identification of the instructive and permissive factors and their signaling pathways will provide 
leads for prevention and treatment (including cell replacement) of neurodegenerative and other diseases of the 
brain. Cerebellum-hippocampus transplantation experiments have suggested the importance of factors released 
by the donor and/or host cells in neurogenesis (Yoshimura, 2001; Tao, 1997; Borghesani et al., 2002) and cell 
fate decisions (Renfranz et al., 1991; Vicario-Abejón, 1995; Suhonen, 1996; Alder et al., 1999). Granule cells 
of the cerebellum and hippocampal dentate gyrus share several morphological commonalities (Ramon y Cajal, 
1911); also, they both display dependencies on, or expression of, a common set of growth factors and signaling 
pathways (Dreyfus, 1998). On the other hand, cerebellar and hippocampal granule cells show distinct 
differences in their repertoire of glutamate receptor subtypes (Monyer et al., 1994) and gene expression profiles 
(Saito et al., 2002), features that most likely reflect their different physiological roles. These similar, but also 
divergent, properties make these two types of granule neuron interesting models for analyzing the intrinsic 
factors responsible for the regulation of their proliferation and maturation. Both, dentate and cerebellar granule 
cells first appear late in embryogenesis, with peak numbers appearing during the first postnatal week (Altman 
et al., 1972; Altman and Bayer, 1990; Schlessinger et al., 1975). Hippocampal granule cells continue to 
proliferate throughout life, although the rate of proliferation wanes with age (Altman and Bayer, 1990; Kuhn et 
al., 1996; Cameron and McKay, 2001). In contrast, the genesis of cerebellar granule cells terminates within the 
first 2 weeks of life (Altman, 1972). Interestingly, gene profiling studies revealed that genes involved in 
oncogenesis and ribosomal protein synthesis are most strongly expressed at the peak of cerebellar granule cell 
production (Saito et al., 2002); of the five gene clusters analyzed in that study, none showed any particular 
temporal pattern of expression in the dentate gyrus.  
To examine the hypothesis that tissue-specific factors may serve as ‘start’ and ‘stop’ paracrine controls of 
proliferation in different brain areas, we here measured neurogenesis by the bromodeoxyuridine (BrdU) 
incorporation in immunochemically characterized cells after exchanging conditioned medium (CM) between 
rat postnatal day 4 (P4) hippocampal (proliferating) and P7 cerebellar (non-proliferating) granule cell cultures; 
a similar approach was also used on co-cultures of hippocampal and cerebellar slices derived from differently 
aged donors. Our studies involving a combination of ion exchange chromatography, immunoneutralization and 
manipulation of specific signal transduction pathways reveal that TGF-β2 and BDNF secreted from cerebellar 
granule cells have strong anti-proliferative and neuronal differentiating properties when applied to mitotic 
dentate granule cells.  
 
Materials and Methods 
Primary cell cultures and conditioned medium 
Hippocampal, cerebellar and cortical primary cell cultures were prepared as previously described (Lu et 
al., 2003). Briefly, hippocampal (P4) and cerebellar (P7) cells obtained from Wistar rats aged 4 days were 
digested using the Papain Dissociation System (Worthington Biochemicals); dissociated cells were plated 
on poly-d-lysine-coated glass coverslips at a density of 400 cells/mm2. Cultures were maintained in 
Neurobasal A medium/2% B27 Supplement and 1 Mm GlutamaxI and 0.1 mg/ml kanamycin (Invitrogen) 
in an incubator at 37°C flushed with 5% CO2/95% air and under 90% relative humidity. Half the culture 
medium was renewed every 3 days. Experiments were started 8-14 days after plating. 
 Immunocytochemical analysis revealed that the cultures comprised ca. 40% neurons (neuronal markers 
used: NeuN, TuJ1 and doublecortin), ca. 10% astroglial cells (glial fibrillary acidic protein, GFAP-
positive) and ca. 50% progenitor (nestin-positive) cells. Twenty-four hours before experiments, the 
culture medium was completely replaced with conditioned medium (CM) from either cerebellar 
(CMCerebellum) or hippocampal (CMHippocampus) cultures containing BrdU (20 Μm). Treated cultures were 
fixed with 4% paraformaldehyde (PFA) 24 hours later and processed for the immunocytochemical 
detection of BrdU. 
 
Slice culture 
Cerebellar and hippocampal ‘interface’ slice cultures were prepared from P7 Wistar rats based on a protocol 
published by Noraberg et al. (1999). Briefly, hippocampal and cerebellar slices (400 µm) were placed on 
Millicell® semiporous membranes in 6-well plates (Millipore). Slices from each brain area were placed 
adjacent to each other in a single well, and bathed in 50% OPTI-MEM®/Dulbecco’s modified Eagle’s Medium 
(DMEM), including 10% fetal bovine serum, 15% horse serum, 1 Mm Glutamax, and 0.1 mg/ml kanamycin in 
Hank’s buffered saline solution; all media and additives were from Invitrogen. Co-cultures were maintained at 
37°C (90% humidity) for 16 days, with medium changes every 3 days. Twenty-four hours before fixation (4% 
PFA), cultures were treated with BrdU (20 µM) and propidium iodide (PI, 20 µM; Molecular Probes).  
 
HiB5 hippocampal cell line 
Neural precursor SV40 T large antigen-immortalized HiB5 cells (Renfranz et al., 1991) were kindly provided 
by Dr. Nina Rosenqvist (Lund, Sweden). In all experiments, cells were maintained in DMEM containing 10% 
fetal calf serum and 1% kanamycin at the permissive temperature (32˚C) and a 5% CO2 environment.  
 
Immunocytochemistry 
Slice and dispersed cell cultures were fixed in 4% paraformaldehyde in 0.1 M PBS, permeabilized with 0.3% 
Triton-X100/PBS and incubated in 3% donkey serum/0.3% Triton for 30 minutes. Specimens were then 
incubated (1 hour; room temperature) with primary antibodies, all diluted 1:500 in 3% donkey serum/0.3% 
Triton X-100 in PBS: anti-BrdU (DAKO), anti-Nestin (Chemicon), anti-TuJ1 (Babco), anti-MAP2 (Sigma), 
anti-doublecortin (Santa Cruz Biotechnology), anti-GFAP (Sigma), anti-αMash1 and anti-αMath1 (kind gifts 
from Dr. Jane Johnson, Dallas, TX). After washing in PBS, cells and slices were incubated (30 minutes, room 
temperature) with biotinylated anti-mouse or anti-rabbit secondary antibody (1:500; Sigma). Specimens were 
then washed thoroughly in PBS and incubated (30 minutes, room temperature) with FITC- or horse radish 
peroxidase-conjugated Avidin (1:500; Sigma). HRP was developed with diaminobenzidine (0.025% in 0.001% 
H2O2 in Tris-buffered saline). In some instances, nuclear staining was achieved using Hoechst 33342 (1:1000 
in PBS; 15 minutes; Roche). Specimens were examined using through-light or fluorescence microscopy after 
mounting in appropriate media. Cells staining positive for BrdU or one of the various neural markers were 
counted with respect to the total number of cells in 5 randomly-chosen microscopic fields (0.072 mm2; 
magnification: 400X) across the long axis of each object; an average of 1,000 cells were sampled on each 
coverslip and the results shown represent values from 6-10 coverslips per treatment. 
 
Cell death assay 
 Cell death was examined in 4% PFA-fixed cells by TUNEL histochemistry or Hoechst 33342 staining. For 
TUNEL histochemistry, samples were permeabilized (0.1% Triton X-100) and then treated with a peroxidase-
blocking solution (1% H2O2) before being processed as described previously (Almeida et al., 2000). Apoptotic 
cells were characterized by dark brown nuclear staining; only those nuclei showing evidence of DNA 
fragmentation without plasma membrane damage were considered to be undergoing apoptosis. Hoechst 
staining (see above) was used, randomly, to confirm results obtained using TUNEL. The relative number of 
apoptotic vs. Total number of cells were quantified in at least 5 randomly chosen microscopic fields 
(magnification of 400X).  
 
Western blotting 
Cells were harvested in lysis buffer, briefly sonicated (ice), and lysates were cleared by centrifugation. Proteins 
were electrophoretically resolved on 10 or 8% SDS polyacrylamide gels and transferred onto nitrocellulose 
membranes. Membranes were blocked in PBS containing 5% non-fat milk and 0.2% Tween-20, and incubated 
with specific primary antibodies (anti-MAP2a/b: Sigma, 1:5000; anti-synapsin: Chemicon, 1:400; anti-p21: 
Pharmingen, 1:500; anti-p27: Santa Cruz, 1:200). Antigens were revealed by enhanced chemoluminescence 
(Amersham Biosciences) after incubation with appropriate horseradish peroxidase-IgG conjugates 
(Amersham). 
 
Concentration and purification of conditioned medium from cerebellar cultures (CMCerebellum) 
A total of 1 L of CMCerebellum was collected from cultures between 8 and 14 days in vitro (d.i.v.). A 100-fold 
concentrate, containing peptides with Mr > 6Kda, was prepared using Vivaspin® columns (Vivascience). 
Concentrated CMCerebellum was then run through Q-ion exchange columns (Vivapure® 20; Vivascience), and 
eluted with buffer with a sequential salt gradient. The bio-active fractions were further separated on Affigel 
blue columns (BioRad). All resulting fractions were analyzed by immunocytochemistry for their ability to 
influence BrdU incorporation and  apoptosis as well as the expression of neuronal markers in hippocampal 
cultures.  
 
Heat lability test 
Concentrated (100X) CMCerebellum was boiled for 15 minutes before addition to hippocampal cultures and 
measurement of bioactivity (cell proliferation and neuronal markers, as described above).  
 
Immunoneutralization  
Antibodies against brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were purchased 
from Santa Cruz Biotechnology; antibodies against TGF-β2 were from R&D Systems. CMCerebellum was 
adsorbed with these antisera for 1 hour (room temperature) before being added to cell cultures at dilutions 
ranging from 1:10 to 1:10,000 after which the biological activity of the CMCerebellum was assessed as described 
before.  
 
BDNF studies 
Results from the BDNF immunoneutralization experiments were confirmed by adding BDNF (Hbdnf, 10-100 
ng/ml; Alomone Laboratories) to hippocampal cultures on 7 d.i.v., and monitoring for BrdU incorporation and 
MAP2a/b expression after 24 hours.  
 Further verification of BDNF effects was obtained by transiently transfecting primary hippocampal cultures 
with a BDNF expression vector (pcDNA3-BDNF-Citron, kindly provided by Dr. Oliver Griesbeck, 
Martinsried, Germany); Pegfp was used as a control. Transfection was carried out using 1 µg DNA/well and 
Lipofectamine 2000® (Invitrogen) under serum-free conditions. Twenty-four hours after transfection, media 
were exchanged between BDNF- and EGFP-transfected cells, and BrdU (20 µM) was added to the cultures. 
BrdU incorporation was assessed after a further 24 hours.  
MAP kinase mediation of the pro-mitotic actions of BDNF was examined by assaying BrdU retention after 
treating cultures with the MEK1/2 inhibitor UO126 (Cell Signaling; 5 µM). The ability of BDNF (100 ng/ml) 
to stimulate cytoplasm-to-nucleus translocation of key TGF-β signaling partners was analyzed by transiently 
transfecting hippocampal cultures with fluorescence-tagged Smad2 and Smad4 (see below) and microscopic 
examination.  
 
Smad nuclear translocation  
To study nuclear translocation of Smad, primary hippocampal neurons, grown for 7 days in 12-well dishes, 
were transfected with Pegfp-Smad2 or Pegfp-Smad4 (kindly provided by Dr. Kelly Mayo, Evanston, IL). 
Transfection was carried out using 1 µg DNA/well and Lipofectamine 2000® (Invitrogen) under serum-free 
conditions. Transfection efficiency, judged in control transfections with Pegfp, was approximately 5%. 
Following transfection, cells were returned to standard growing medium or CMCerebellum for a further 24 hours 
before staining with Hoechst 33342 and microscopic examination.  
 
Smad signaling and cell proliferation 
Analysis of Smad signaling in the control of proliferation was studied in primary hippocampal cells after 
transfection (see above) with 1 µg/well of the following plasmids generously provided by Dr. Joan Massague 
(New York, NY; Pcs2-FLAG-Smad3 (Smad3 wild type), Pcs2-FLAG-Smad3(3S-A; Smad3 dominant 
negative), Pcmv5-FLAG-DPC4 (Smad4 wild type), Pcmv5-FLAG-DPC4(1-514; Smad4 dominant negative); 
Pegfp was used as an internal control. Twenty-four hours after transfection and exposure to either control or 
CMCerebellum, TGF-β2 (1 ng/ml) or BDNF (100 ng/ml), the number of BrdU-positive cells relative to the total 
number of (Hoecahst 33342-stained) cells was assessed.  
 
3TP-Lux reporter assay 
The p3TP-Lux reporter gene, containing a known TGF-β-inducible plasminogen activator inhibitor promoter 
(Wrana et al., 1994) and kindly provided by Dr. J. Massague, was transfected into HiB5 cells seeded in 24-well 
plates (4x104 cells per well), together with wildtype or dominant negative Smads. Plasmid (625 ng of total 
DNA) was introduced using Lipofectamine 2000® into cells maintained in Neurobasal A medium/2% B27 
Supplement and 1 Mm GlutamaxI and 1% kanamycin (all from Invitrogen). Twenty-four hours after 
transfection, cells were treated with CMCerebellum (10 µl/ml). Cells were harvested 24 h thereafter in 100 µl of 1X 
lysis buffer (Promega) and centrifuged. The cleared supernatants were assayed for β-gal and luciferase activity. 
For β-gal detection, 10µl of cellular extract was mixed with 100 µl of β-gal buffer (60 Mm Na2HPO4, 40 Mm 
NaH2PO4, 10 Mm KCl, 1 Mm MgCl2, 2 Mm β-mercaptoethanol) and 20 µl of O-nitrophenyl-β-D-
galactopyranoside (Sigma). The reaction was terminated with 50 µl of Na2CO3 (1M) and luciferase activity was 
measured by mixing 30 µl of cellular extract with 50 µl of a buffer containing 75 Mm Tris-HCl and 1 Mm 
MgCl2 (Ph 8). Substrate D-(-) Luciferin (1 Mm) was automatically injected and light emission (410 nm) was 
measured over 20 s in a luminometer. 
 Statistical analysis 
All data are depicted as means + S.D. and represent the observations from 3-5 independent experiments, with 
3-4 replicates for each data point. Data were analyzed for statistical significance using ANOVA and 
appropriate post-hoc tests (Student-Newman-Keuls or Kruskal-Wallis multiple comparison procedures) in 
which P < 0.05 was set as the minimum level of significance.  
 
Results 
Spontaneous neuronal proliferation and apoptosis (Fig. 1A) 
Hippocampal and cerebellar cultures (8-19 d.i.v.) displayed a dense network of TuJ1-positive neurites (TuJ1 
antibody labels neuron-specific tubulin β III). Confirmation that the cerebellar cultures contained post-mitotic 
neurons was provided by staining for the basic Helix-Loop-Helix (Bhlh) transcription factor Math-1, known to 
be essential for cerebellar granule cell development (Ben-Arie et al., 1997), and for the neuronal commitment 
gene Mash-1 (Ross et al., 2003). Hippocampal cultures did not stain for Math-1 but were Mash-1-positive; as 
in the cerebellum, Mash-1 marks immature neurons in the hippocampus (Pleasure et al., 2000).  
Both cerebellar and hippocampal cultures displayed mitosis (BrdU incorporation; blue-black nuclei;) and 
apoptosis (brown-stained TUNEL-stained cells showing evidence of nuclear fragmentation), shown in the 
second column of Fig. 1A. 
 
Cerebellar ‘stop’ signals vs. Hippocampal ‘go’ signals  (Fig.1B-F) 
To test the hypothesis that cerebellar cells secrete factors that serve as an ‘instructive’ microenvironment, BrdU 
incorporation (24 hours) by hippocampal cultures maintained in conditioned medium derived from cerebellar 
cultures (CMCerebellum) was examined using immunocytochemistry. As shown in Fig. 1B, exposure to 
CMCerebellum resulted in a significant reduction in BrdU incorporation (p < 0.001). In a reverse experiment, 
cerebellar cultures treated with CMHippocampus showed a significant increase in the relative number of cerebellar 
cells that stained positively for BrdU (p < 0.01) (Fig. 1C). Similar results were obtained in studies where 
hippocampal (4-day old donors) and cerebellar (7-day old donors) slices were used. During the last 24 hours of 
co-culture (14 days), slices were treated with BrdU (20 µM) and BrdU retention was subsequently monitored 
by immunocytochemistry. As Fig. 1E shows, cell proliferation in hippocampal slices was significantly reduced 
in the presence of cerebellar slices as compared to when hippocampal slices were grown alone (p < 0.01); in 
contrast, cell proliferation in cerebellar slices was slightly, but not significantly, increased in the presence of 
hippocampal tissue.  
Besides braking proliferation in hippocampal slices, cerebellar slices also induced cell death in the former, as 
monitored by the significant retention of propidium iodide (PI) in hippocampal tissue (P < 0.05); in contrast, 
the presence of hippocampal tissue did not influence the number of dying cells within cerebellar slices (Fig. 
1F). Representative images of BrdU- and PI-stained co-cultures are shown in Supplementary Figs. IA-D and 
Figs. 1E-H, respectively. 
The above results indicate that soluble factors with mitotic and anti-proliferative properties are secreted into 
CMHippocampus and CMCerebellum, respectively. Further, it was shown that the anti-mitotic effects of CMCerebellum  
were restricted to hippocampal cells insofar that its addition did not influence proliferation in cortical primary 
cultures (Fig. 1D). From this point, our studies were focused on the anti-proliferative activity of CMCerebellum on 
hippocampal cells. 
 
Specificity and dose- and time-dependency of CMCerebellum effects, and physical properties of the 
 bioactive moieties present in CMCerebellum (Fig.2A, B) 
Incubation of hippocampal cell cultures with varying volumes of 100-fold concentrated CMCerebellum established 
that the putative anti-proliferative factors in CMCerebellum dose-dependently influence BrdU incorporation (Fig. 
2A). Further, as shown in Fig. 2B, significant inhibition of BrdU incorporation was observed as early as 3 
hours following addition of 10 µl of 100X concentrated CMCerebellum (p < 0.001). Significant inhibitory effects 
of CMCerebellum were still observable after 24h (p < 0.05), but these were absent after 48 and 72 hours. Notably, 
there was a gradual and significant, time-dependent decline in the proliferative potential of hippocampal cells 
under basal conditions (fresh control medium vs. CMCerebellum). Also, it should be noted that there was no 
increase in the rate of apoptosis during the first 12 hours after addition of concentrated CMCerebellum (data not 
shown). 
An insight into the physico-chemical nature of the putative factor(s) contributing to the anti-proliferative 
activity of CMCerebellum was gained by assaying the effects of boiled 100-fold concentrated CMCerebellum on BrdU 
incorporation by recipient hippocampal cells. As Fig. 2A (last column) shows, the anti-mitotic activity of 
CMCerebellum was abolished by boiling for 15 minutes; boiling CMCerebellum for 5 minutes did not influence 
biological activity (data not shown). These findings point to the peptidergic/proteinaceous nature of the anti-
proliferative moieties present in CMCerebellum.  
CMCerebellum induces expression of negative regulators of the cell cycle and markers of neuronal 
differentiation (Fig.2C-F) 
Western blot analysis showed that treatment of hippocampal cultures with  CMCerebellum induces expression of 
the cyclin-dependent kinase inhibitors p21 and p27 (Fig. 2C), indicating that the anti-proliferative effects of 
CMCerebellum result from its ability to interfere with progression through the cell cycle.  
The anti-mitotic effects of CMCerebellum were found to be associated with enhanced numbers of cells displaying 
signs of neuronal maturity: hippocampal cultures grown in CMCerebellum showed a small but significant (p < 
0.05) decrease in the number of cells immunoreactive for doublecortin (Fig. 2E), the marker of early post-
mitotic neuroblasts, and a significant increase (p < 0.01) in the relative number of cells that demonstrated 
MAP2a/b immunoreactivity (Fig. 2D). Increases in MAP2a/b were seen in immunofluorescence and by 
Western blot analysis. In addition, as also shown in Fig. 2D, hippocampal cultures treated with CMCerebellum also 
showed increased expression of synapsin in Western blots. Interestingly, CMCerebellum had no significant effect 
on the relative number of glial (GFAP-immunopositive) cells in the hippocampal cultures (Fig. 2F).  
The above findings indicate that biological factors present in CMCerebellum can induce cell cycle arrest within that 
subpopulation of cells destined to become neurons while, at the same time, accelerating neuronal maturation.  
 
Presence of multiple factors with differing anti-proliferative, apoptotic and differentiation-inducing 
properties in  CMCerebellum (Table 1) 
Working on the premise that more than one factor may account for the anti-mitotic actions of CMCerebellum on 
hippocampal cell cultures, concentrated CMCerebellum was fractionated according to ionic strength after 
minimizing albumin interference using Affigel Blue chromatography. The 4 fractions that were eluted with 
NaCl (0.1-1.5 M) showed differing potencies on the proliferative, apoptotic and differentiating potential of 
hippocampal cells (Table 1). Specifically, fractions eluting at 0.1 M NaCl had significant anti-mitotic (p < 
0.001) and anti-apoptotic (p < 0.05) activities; strong anti-apoptotic activity was observed in eluates containing 
1.5 M NaCl (p < 0.001), and fractions eluting at 1 M NaCl proved effective at promoting neuronal maturation 
(p < 0.05). These results show that CMCerebellum contains a cocktail of factors that can differentially influence 
hippocampal cell fate. 
  
Identification of anti-proliferative and differentiating factors (Fig. 3) 
Some of the above experiments indicated that the active factor(s) of interest in CMCerebellum were heat unstable 
and of a Mr > 6 kDa. Immunoneutralization was used as a first identification approach; 3 candidate trophic 
factors, previously implicated in neuronal birth, differentiation and death, namely, NGF, BDNF, and TGF-β2 
(Minichilo et al., 1996; Massague et al., 2000; Borghesani et al., 2002; Vaudry et al., 2003) were chosen for 
analysis of effects on BrdU incorporation and differentiation (MAP2a/b expression). Immunocytochemistry 
showed the presence of all these peptides in cerebellar and hippocampal cultures (see Supplementary Fig. 2). 
BrdU incorporation by hippocampal cells was not affected after incubation in anti-NGF-preadsorbed 
CMCerebellum (Fig. 3A). Anti-BDNF (1:10) significantly blocked the anti-proliferative effects of crude 
CMCerebellum (p < 0.05; Fig. 3B), as did anti-TGF-β2 (1:1000 and 1:100; p < 0.01; Fig. 3C).  
In accordance with our earlier results that showed that CMCerebellum concomitantly blocks proliferation of 
hippocampal cells while promoting their maturation (Fig. 2), immunoneutralization against TGF-β2 (antibody 
concentrations that proved efficient at reversing the anti-mitotic effects) significantly reduced MAP2a/b 
expression (p < 0.01; Fig. 3D). In contrast, anti-NGF (which did not influence proliferation) and anti-BDNF 
did not alter the relative number of MAP2a/b-immunoreactive cells as compared to CMCerebellum that had not 
been pre-adsorbed with these antisera (Fig. 3D).  
Replication of CMCerebellum effects with exogenous BDNF and insights into signaling pathways involved 
(Fig. 4) 
Immunoneutralization experiments provide only qualitative information and may be compromised by factors 
such as antibody affinity and purity. We pursued analysis of the contribution of BDNF by comparing 
proliferation and maturation in hippocampal cells grown in either CMCerebellum or normal medium to which 
BDNF was added. Significant reductions in BrdU incorporation were observed after treatment with 50 ng/ml (p 
< 0.05) and 100 ng/ml (p < 0.001) (Fig. 4A).  
Similarly, as depicted in Fig. 4B, transfection of hippocampal cells with a plasmid expressing BDNF 
significantly inhibited cell proliferation compared to cells transfected with Pegfp (p < 0.001). Also, when 
medium from Pbdnf-transfected cells (24 hours) was added to Pegfp-transfected cells, proliferation was 
inhibited (third bar in Fig. 4B; p < 0.01). 
In addition to inhibiting cell proliferation, exogenous BDNF at doses between 10 and 100 ng/ml were found to 
promote neuronal maturation; this was seen as a significant increase in the number of MAP2a/b-
immunopositive cells after neurotrophin treatment (p < 0.01; Fig. 4C). In addition, BDNF (100 ng/ml) 
stimulated neurite extension (‘long neurites’ defined as neurites with lengths > twice the diameter of the cell 
body) within 24 hours of application (p < 0.01; Fig. 4C).  
The above findings indicate that exogenous BDNF can largely replicate the effects of CMCerebellum, suggesting 
that BDNF might be an ‘upstream player’ in the manifestation of CMCerebellum actions. Since BDNF signaling 
pathways reportedly converge on those triggered  by TGF-β2 following the neurotrophin’s activation of 
ERK1/2 (Segal and Greenberg, 1996; Pera et al., 2003), we pharmacologically tested the involvement of these 
kinases using the MEK1/2 inhibitor UO126. As shown in Fig. 4D, UO126 significantly abrogated the 
inhibitory effects of CMCerebellum on BrdU incorporation (p < 0.01). These observations, indicating that BDNF-
induced effects on proliferation are mediated through MAP kinases are consistent with earlier reports 
(Marshall, 1995; Du et al., 2003). 
Earlier studies suggested that TGF-β2 signaling pathways may mediate some BDNF actions (Sometani et al., 
2001). To confirm that BDNF can initiate a cascade leading to activation of TGF-β2, hippocampal cells were 
 transiently transfected with 3TP-Lux, a reporter gene containing TGF-ß-responsive elements derived from the 
plasminogen activator inhibitor 1 (Wrana et al., 1994), and subsequently treated with BDNF. As Fig. 4E 
shows, BDNF at the highest concentration tested (100 ng/ml) significantly stimulated luciferase activity (p < 
0.01); similar observations were made in Pbdnf-transfected HiB5 cells (data not shown). Further support that 
other signaling molecules such as TGF-β2 might contribute to the biological effects of BDNF is provided by 
the results shown in Fig. 4F: exposure of hippocampal cultures to BDNF led to increased nuclear translocation 
of Smad2 and Smad4, both of which are crucial for transducing the TGF-β2 signal; pretreatment with 
cyclohexamide was used to exclude BDNF-stimualted de novo synthesis of proteins (e.g. TGF-β2). 
 
Exogenous TGF-β2 reproduces effects of CMCerebellum (Fig.5A and 5B) 
We also analyzed the contribution of TGF-β2 by comparing proliferation and maturation in hippocampal cells 
grown in either CMCerebellum or normal medium to which TGF-β2 was added. Significant reductions in BrdU 
incorporation were observed after treatment with TGF-β2 at 1 ng/ml (p < 0.01) and 10 ng/ml (p < 0.01) (Fig. 
5A). In addition to inhibiting cell proliferation, exogenous TGF-β2 (1 and 10 ng/ml) was found to promote 
neuronal maturation, as evidenced by a significant increase in the number of MAP2a/b-immunopositive cells (p 
< 0.05; Fig. 5B). In addition, TGF-β2 (1 ng/ml) stimulated neurite extension within 24 hours of application (p 
< 0.01; Fig. 5B).  
 
Nuclear translocation of Smads after CMCerebellum treatment (Fig. 5C) 
TGF-β exerts its biological actions through the mediation of SMAD proteins. Smad2 and Smad3 are specific 
transducers of TGF-β. Smad2,3 dimerize with Co-Smad4, as do Smads specific to other cytokines (e.g. BMP2-
linked Smads1,5,8); these complexes translocate to the nucleus where they influence the transcriptional 
machinery (Attisano and Wrana, 2002). Here, we demonstrate that transfection of primary hippocampal 
neurons with either Pegfp-Smad2 or Pegfp-Smad4 followed by exposure to CMCerebellum results in translocation 
of the EGFP-tagged proteins to the nucleus (Fig. 5C), indicating that CMCerebellum contains (an) activator(s) of 
Smad2 and Smad4. While the Smad2 result strengthens the likelihood that TGF-β is one of these factors, it 
cannot be ruled out that Smad4 translocation resulted after complexing with Smads activated by other members 
of the TGF superfamily.  
 
Dominant negative Smad3 and Smad4 abrogate the anti-proliferative and differentiating effects of 
CMCerebellum (Fig. 5D and 5E) 
CMCerebellum failed to inhibit proliferation in primary hippocampal cells expressing dominant negative forms of 
Smad3 (Pcs2-FLAG-Smad3-3SA) or Co-Smad4 (Pcmv-FLAG-DPC4(1-514) (Fig. 5D), again indicating that 
TGF-β may be (one of) the major anti-proliferative factor(s) in CMCerebellum. Participation of other Smad-linked 
factors cannot, however, be excluded, since Co-Smad4 complexes with other members of the Smad family, 
independently of TGF-β; indeed, since the effects of functional inhibition of Smad4 were significantly greater 
(p < 0.01) than those resulting from Smad3 inhibition, activation of other Smad pathways by non-TGF-β 
ligands is highly plausible.  
In contrast to control-transfected cells, cells expressing dominant negative Smad3 and Smad4 showed reduced 
relative numbers of MAP2a/b-positive cells after exposure to CMCerebellum, demonstrating these Smads to be 
involved in signaling the effects of (a) maturation-promoting factor(s) present in CMCerebellum (Fig. 5E). As 
mentioned before, Co-Smad4 dimerizes with Smad targets that are not activated by TGF-β. Since the inhibition 
 of Smad4 was here found to have significantly stronger effects on neuronal maturation than inhibition of 
Smad3 (p < 0.01), a role for other Smad-coupled factors cannot be excluded.  
 
Transactivation of 3TP-Lux following CMCerebellum treatment (Fig. 5F-5H) 
As already mentioned, 3TP-Lux is a reporter gene that specifically responds to TGF-β. Hippocampus-derived 
HiB5 cells (shown to dose-dependently respond to the anti-proliferative effects of CMCerebellum, Fig. 5F) 
transfected with 3TP-Lux (Fig.5G) or co-transfected with 3TP-Lux and wildtype Smad3 or Smad4 (Fig. 5H) 
responded to CMCerebellum by driving luciferase expression, an effect was not seen when dominant negative 
forms of the two Smads were transfected (Fig. 5H). It should be noted that expression of the dominant negative 
plasmids markedly reduced the luciferase response in cells maintained in control (i.e. not CMCerebellum) medium 
(Figs. 5H); this finding suggests that HiB5 cells normally secrete a factor (putatively TGF-β) that can 
transactivate 3TP-Lux. Thus, the immortalized HiB5 cell line appears to be a convenient model for future 
studies.  
 
Discussion 
The pluripotency of neural cell progenitors (McConnell and Kaznowski, 1991; Coskun and Luskin, 2002) 
implies that their ultimate phenotype can be influenced by environmental factors. Phenotypic respecification 
has been demonstrated, for example, in studies involving hippocampal granule cell transplants into the 
cerebellum (Renfranz et al., 1991) and vice versa (Vicario-Abejón et al., 1995). This adaptive capacity, which 
indicates an interplay between lineage-specific and extrinsic factors, is gradually lost with time as the host 
environment becomes increasingly differentiated (Suhonen et al., 1996; Alder et al., 1999), indicating the 
importance of temporal and spatial organization. Another intriguing aspect of neuronal development concerns 
the determination of optimal neuronal population sizes. It is recognized that rates of apoptosis and neurogenesis 
from embryonic development through to adulthood occur in a balanced manner. Earlier studies suggested that 
autocrine or paracrine secretions may play a role in the proliferation, survival and differentiation of developing 
granule neurons (Gao et al., 1991; Mumm et al., 1996; Ueki et al., 2003; Wu et al., 2003). Although various 
experimental paradigms have indicated regulatory roles for the neurotrophin BDNF (Lin et al., 1998; 
Borghesani et al., 2002) and other cytokines such as Bfgf (Tao et al., 1997) and members of the TGF-β 
superfamily (Unsicker and Strelau, 2000; Pratt and McPherson, 1997; Alder et al., 1999; Angley et al., 2003) 
in these events, little is known about the identity of the intrinsic and environmental signals that maintain the 
equilibrium between neuronal birth, maturation and death.  
The appearance and differentiation of cerebellar and hippocampal granule neurons overlap only transiently: 
cerebellar granule cells enter a post-mitotic state at PND 7-14, i.e. when hippocampal granule cell neurogenesis 
is at its peak before gradually declining with increasing age (Schlessinger et al., 1975; Altman and Bayer, 
1990; Cameron and McKay, 2001). A recent DNA microarray analysis revealed that cerebellar and 
hippocampal granule cells display distinct gene expression profiles even at times when both cell types are 
undergoing rapid mitosis (Saito et al., 2002).  
In an analogous approach to ones used previously in animals (Renfranz et al., 1991; Vicario-Abejón et al., 
1995), the different developmental profiles in the hippocampus and cerebellum were exploited in the present 
study to identify cerebellar granule cell-specific factors which can reduce hippocampal granule cell 
proliferation and promote their differentiation. Using granule cell cultures from each brain area, and originating 
from same-aged animals, and immunocytochemical markers of neuronal maturity (MAP2a/b, TuJ1, Mash1 and 
Math1) and proliferative potential (BrdU incorporation) we first confirmed that, as compared to hippocampal 
 cultures, the cerebellar cultures were more mature and mainly post-mitotic after 14 d.i.v. Next, cultures of one 
type were treated with conditioned medium from the other (CMCerebellum and CMHippocampus). Analysis of BrdU 
uptake revealed that whereas CMHippocampus stimulated proliferation in cerebellar cultures, CMCerebellum treatment 
inhibited cell proliferation and accelerated neuronal maturation in the hippocampal cultures; the latter events 
were accompanied by increased expression of two cell cycle arrest-related molecules, p21 and p27. Similar 
results were obtained with hippocampus-cerebellum slice co-cultures, as well as when a hippocampus-derived 
cell line (HiB5) was treated with CMCerebellum. The anti-proliferative effects of CMCerebellum had a rapid onset 
(first detectable increases in BrdU incorporation being observed after 3 hours) and were dose-dependent. 
Together, these results indicate that cerebellar and hippocampal cells secrete cell-type specific factors which 
have distinct influences on neurogenesis and differentiation. The view that cultures from each brain area 
secrete unique biologically-active substances was further supported by the finding that the incidence of 
apoptosis in hippocampal slices was increased in the presence of cerebellar slices, but not vice versa. Lastly, 
target specificity of these effects was reflected by the fact that CMCerebellum failed to influence proliferation in 
cortical cultures.  
Hints that the active anti-proliferative/pro-differentiating factor(s) in CMCerebellum were polypeptidergic in nature 
were provided by observations that boiling resulted in a loss of biological activity. Importantly, biological 
potency was retained in CMCerebellum that was subjected to ion exchange chromatography (fractions contained 
material with Mr > 6 kDa), but the anti-mitotic, apoptotic and differentiating activities eluted at different ionic 
strengths. Immunoneutralization of the various fractions was subsequently used in a first attempt to identify the 
active moieties. Our choice of candidates for initial neutralization was based on the differential expression of 
TGF-β2, NGF and BDNF in hippocampal and cerebellar tissues during development (Unsicker et al., 1991; 
Sakamoto et al., 1998; Dieni and Rees 2002; also see Supplementary Fig. 2). Those studies showed that 
neutralization of BDNF and TGF-β2 activities reversed the anti-proliferative actions of CMCerebellum, whereas 
anti-NGF treatment had no effect on this parameter. At the same time, the pro-differentiating effects of 
CMCerebellum were found to be reversed by pre-adsorption of CMCerebellum with anti-TGF-β2, but not with  anti-
BDNF or –NGF.  
Further studies were focused on verifying the roles of TGF-β2 and BDNF in the observed CMCerebellum-induced 
effects on hippocampal cell development. Immunocytochemistry demonstrated that BDNF is strongly 
expressed in cerebellar cultures but only weakly in hippocampal cultures (Supplementary Fig. 2). Treatment of 
hippocampal cultures with exogenous BDNF resulted in an inhibition of BrdU uptake and an increase in 
neuritic lengths and the number of MAP2a/b neurons. Transfection of cells with a BDNF-expressing plasmid 
provided similar results on BrdU incorporation. BDNF effects on neuronal differentiation are known to be 
mediated through TrkB receptors (Klein et al., 1991) and, depending on the strength and duration of the 
stimulus, BDNF either promotes or inhibits neuronal proliferation by activating the Trk-MAPK-ERK pathway 
(Marshall, 1995; Du et al., 2003). This prompted us to examine whether ERK signaling is involved in the 
biological actions of CMCerebellum. Activation of the ERK1/2 pathway was previously shown to block Smad in 
Xenopus embryos (Pera et al., 2003); in contrast to that finding, we here observed UO126, an inhibitor of 
MEK1/2 to negate the actions of CMCerebellum on proliferation. While a plausible explanation for these 
discrepant findings is lacking, the present data is supported by our observation that BDNF treatment can elicit a 
response from the TGF-β reporter gene, 3TP-Lux, as well as the ability of BDNF to increase the cytoplasm-to-
nucleus translocation of Smad2 and Smad4, two key players in TGF-β signaling. At this stage, the exact 
intracellular mechanisms that underpin this cross-talk between BDNF-TGF-β remain unknown, but it is 
 pertinent to mention that previous authors also obtained evidence for cross-talk (cf. Lutz et al., 2004) or 
interdependence/synergism (cf. Unsicker and Strelau, 2000) between these trophic factors. 
There are three isoforms of TGF-β, each derived from separate genes: TGF-β1 whose expression is normally 
restricted to the choroid plexus, and TGF-β2 and TGF-β3 which are expressed in neurons and glia (Unsicker et 
al., 1991; Pratt and McPherson, 1997). TGF-β1 and TGF-β3 have been implicated in neuroprotection, while 
neurotrophic functions have been ascribed to TGF-β2 and TGF-β3 (Finch et al., 1993; Böttner et al., 2000; 
Pratt and McPherson, 1997). The latter include stimulation (Mahanthappa and Schwarting, 1993) or inhibition 
(Constam et al., 1994) of neurogenesis, or both (Kane et al., 1996), as well as the regulation of neuronal 
differentiation (Ishihara et al., 1994; Abe et al., 1996; Cameron et al., 1998). TGF-β2, the isoform focused on 
in this work, is expressed in the external granular (neurogenic) layer and in Purkinje and radial glia of the 
cerebellum according to a strict temporal pattern and interestingly,  appreciable levels of TGF-β2 are not seen 
in other brain sites of neuronal proliferation (Flanders et al., 1991; Constam et al., 1994; Unsicker and Strelau, 
2000). The expression profiles seen in vivo held true in our cultures: TGF-β2 was much stronger in cerebellar 
vs. Hippocampal cells (Supplementary Fig. 2). These observations, together with those on the distribution of 
TGFβ receptors (TGFβR; see below) imply that ligand/receptor availability govern the specific time window 
within which proliferation and differentiation can occur.   
Members of the TGF-β superfamily signal by sequentially binding to two TGFβR which are transmembrane 
protein serine/threonine kinases; in the case of TGF-β, ligand binding to TGFβR-II activates TGFβR-1; both 
the developing and rat adult hippocampus express TGFβR-II Mrna (Böttner et al., 1996). Receptor-regulated 
SMAD proteins (R-SMADs) serve as TGFβR-1 substrates which, upon phosphorylation, subsequently bind 
Co-Smad4 and translocate to the nucleus where they form a transcriptionally active complex after association 
with DNA-binding partner(s). This last complex binds to promoter elements of target genes whose functions 
include regulation of the cell cycle, differentiation and cell adhesion, positioning, and movement (Moustakas et 
al., 2001; Chang et al., 2002; Shi and Massagué, 2003). For example, cell cycle arrest by TGF-β involves 
suppression of the oncogene Myc, a repressor of the cyclin-dependent kinase inhibitors, p21 and p27 (Seoane 
et al., 2002; Gartel and Shchors, 2003). Supporting the view that TGF-β2 may be responsible for at least some 
of the antimitogenic activity of CMCerebellum we here observed an upregulation of p21 and p27 after CMCerebellum 
treatment of proliferating hippocampal neurons.  
Additional evidence for a key role of TGF-β2 in the hippocampal cell fate-determining actions of CMCerebellum 
was obtained in a series of experiments focused on the TGF-β signal-propagating SMAD proteins. Of the 
various members of the SMAD system, Smad2 and Smad 3 mediate TGF-β signals, but also those of activin, 
another member of the TGF-β superfamily. Smad4 is a requisite partner for transcriptional activity of  Smads2 
and 3, as well as Smads1, 5 and 8 which are substrates of the bone morphogenetic proteins (BMP); the 
generation of specific downstream responses presumably depends on the formation of particular R-SMAD-
Smad4 complexes which then recruit different sequence-specific DNA-binding factors (Massagué and Wotton, 
2000). Here, we demonstrated that CMCerebellum treatment can induce nuclear translocation of EGFP-Smad2 and 
–Smad4. Consistent with previous results showing that Smad2 translocation does not require Smad4 (Liu et al., 
1997), we observed that translocation occurred to a similar extent in cells transfected with the individual 
plasmids or co-transfected with EGFP-Smad2 and GFP-Smad4. Essential roles for Smad3 and Smad4 were 
also demonstrated insofar that expression of the dominant negative forms of either of these molecules 
prevented the transactivation of 3TP-Lux by CMCerebellum and abrogated the anti-proliferative and pro-
differentiating effects of CMCerebellum in hippocampal cultures.  
 In summary, we have demonstrated that TGF-β2, acting in a paracrine fashion, plays a key role in determining 
hippocampal cell fate, namely by inhibiting cell proliferation and promoting neuronal differentiation. TGF-β2 
is expressed at moderate levels in the adult hippocampus (Unsicker et al., 1991) but is only weakly detectable 
by immunocytochemistry in early postnatal hippocampal cells; however, the developing hippocampus appears 
to have all the signaling machinery required to respond to TGF-β2 of extra-hippocampal origin. Our studies 
also show that BDNF, better known for Trk receptor-mediated promotion of neurogenesis and differentiation 
(Klein et al., 1991; Gao et al., 1995; Pencea et al., 2001), can exert anti-proliferative effects on hippocampal 
granule cell neurons by activating ERK1/2 and subsequently, TGF-β2 signaling pathways. The effects of this 
neurotrophin are also likely attributable to non-hippocampal sources since BDNF expression in the early 
postnatal hippocampus is poor (Friedman et al., 1991). While it remains to be seen whether the reported 
findings represent independent, interdependent, or parallel actions of BDNF and TGF-β2, our experiments 
identify two distally-produced growth factors, sharing common downstream signaling pathways that act in a 
temporally co-ordinated fashion to control neuronal proliferation and maturation. 
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Fig. 1. Cerebellar ‘stop’ vs. hippocampal ‘go’ signals. 
(A) Characteristics of hippocampal and cerebellar neuronal cultures under basal conditions, showing 
expression of the neuronal markers TuJ1, Mash1 and Math1, and levels of apoptosis (TUNEL) and 
proliferation (BrdU incorporation). Exposure of hippocampal cells to CMCerebellum reduces BrdU incorporation 
(B); exposure of cerebellar cultures to CMHippocampus stimulates BrdU uptake (C); CMCerebellum does not influence 
proliferation in cortical neurons (D). In hippocampal-cerebellar slice co-cultures, hippocampal cell proliferation 
is reduced in the presence of cerebellar slices, whereas cerebellar cell proliferation is slightly increased in the 
presence of hippocampal tissue (E). Cell death (propidium iodide assay) is increased in hippocampal, but not 
cerebellar, cells in hippocampal-cerebellar slice co-cultures (F). Scale bars in (A) represent 50 µm. Here and in 
all subsequent figures, numerical data refer to means + s.e.m. (n = 4-6). *, ** and *** indicate P < 0.05, 0.01 
and 0.001, respectively.   
  
Fig. 2. Hippocampal cultures express markers of cell cycle inhibition and neuronal differentiation after 
incubation in CMCerebellum. 
Dose- and time-dependency of CMCerebellum anti-mitotic effects in hippocampal cultures (A,B); anti-proliferative 
activity of CMCerebellum is abolished by boiling (A). Western blots and/or immunofluorescence showing that 
addition of CMCerebellum to hippocampal cultures induces expression of the cyclin-dependent kinase inhibitors 
p21 and p27 (C) and of the mature neuron markers MAP2A/B and synapsin (D); concomitantly, expression of 
the neuroblast marker doublecortin is decreased (E). Proliferation of GFAP-positive glial cells is not affected 
by CMCerebellum treatment (F).  
   
Fig. 3. Immunoneutralization of candidate anti-proliferative and differentiating factors in CMCerebellum. 
CMCerebellum was preadsorbed with the indicated dilutions of anti-NGF (A), BDNF (B), or TGF-β2 (C,D). 
Immunoneutralization of BDNF and TGF-β2 significantly attenuated the anti-proliferative actions of 
CMCerebellum; anti-TGF-β2 significantly attenuated the pro-differentiating effects of CMCerebellum, assessed  by 
MAP2A/B expression (D).  
 
  
Fig. 4. Exogenous BDNF replicates CMCerebellum actions through the mediation of ERK1/2 and TGF-β2 
signaling pathways. 
(A) BDNF peptide dose-dependently inhibits BrDU retention in hippocampal cells. (B) Comparison of the first 
two bars shows that hippocampal cells transiently transfected with pBDNF show reduced BrdU incorporation; 
control transfections were done with pEGFP. Inhibition of BrdU uptake is also seen in cells exposed to CM (24 
hours) from cells transfected with pBDNF (third bar). (C) BDNF stimulates maturation of hippocampal 
cultures (increased expression of MAP2A/B and neurons with neurite lengths > two times the diameter of the 
soma). (D) The MEK1/2 inhibitor, UO126 (5 µM), counteracts the anti-proliferative effects of BDNF. (E) 
Increases in the transactivation of the TGF-β-responsive 3TP-Lux reporter gene by BDNF in primary 
hippocampal cells implicates mediation of BDNF actions by TGF-β signaling pathways. (F) Involvement of 
TGF-β signaling pathways in mediating BDNF actions are also indicated by the ability of BDNF to stimulate 
cytoplasm-to-nucleus translocation of Smad2 and Smad4 (cf. Fig. 5C). In this last experiment, cells were 
pretreated with cyclohexamide (10 µM, 1 hour) before addition of BDNF (1 hour) in order to ensure that any 
BDNF effects observed were not confounded by de novo synthesis of other intermediary factors.  
  
Fig. 5. Involvement of TGF-β2 signaling pathways in the anti-mitotic and differentiating effects of of 
CMCerebellum.  
Exogenous TGF-β2 reproduces the anti-proliferative (A) and pro-differentiating (B) actions of CMCerebellum in 
primary hippocampal cultures. Exposure of hippocampal cells to CMCerebellum induces nuclear translocation of 
the TGF-β2-specific partner Smad2 and of Co-Smad4, as shown by transient transfection experiments (C); for 
comparison, nuclear translocation after TGF-β2 (1 ng/ml) is shown. Introduction of dominant negative forms 
(∆) of either Smad3 which specifically couples with TGF-β2 or of Co-Smad4 abrogates the anti-mitotic (D) 
and differentiating (E) effects of CMCerebellum on primary hippocampal cells. CMCerebellum also exerts anti-
proliferative effects on hippocamus-derived HiB5 cells (F). CMCerebellum stimulates generation of luciferase from 
the 3TP-Lux reporter in HiB5 cells (G); the latter is abrogated when dominant negative forms (∆) of either 
Smad3 or Co-Smad4 are co-expressed.  
 
 
 
 
 
  
TABLE 1 
Multiple factors in  CMCerebellum contribute to its anti-proliferative, apoptotic and differentiation-inducing 
properties. 
Concentrated CMCerebellum was fractionated according to ionic strength and dye affinity using Q and Affigel 
Blue chromatography. The 4 fractions that eluted with NaCl (0.1-1.5 M) differentially influenced proliferation, 
apoptosis and differentiation in primary hippocampal cells. Specifically, fractions with 0.1 M NaCl displayed 
significant anti-mitotic (p < 0.001) and anti-apoptotic (p < 0.05) activities; strong anti-apoptotic activity was 
observed in fractions eluting with 1.5 M NaCl (p < 0.001) whereas those eluting with 1 M NaCl promoted 
neuronal maturation (p < 0.05).  
 
 
 
 SUPPLEMENTARY FIGURES 
 
 
 
Supplementary Fig. 1. Proliferation and apoptosis in hippocampal-cerebellar slices co-cultures.  
Compared to hippocampal slice monocultures (A), hippocampal-cerebellar slice co-cultures (B) stained for 
BrdU show reduced proliferation in hippocampal slices. BrdU incorporation in cerebellar slices was not 
markedly altered by the presence of hippocampal slices (cf. C,D). Hippocampal slices co-cultured with 
cerebellar slices (F) showed stronger retention of propidium iodide, indicating increased apoptosis, as 
compared to hippocampal mono-cultures (E). Propidium iodide staining in cerebellar slices (G) was not altered 
after co-culture with cerebellar slices (H).  
 
 
  
 
 
Supplementary Fig. 2. Differential expression of NGF, BDNF and TGF-β2 in cerebellar and 
hippocampal primary cultures, demonstrated by immunocytochemistry. Note the less intense staining of 
BDNF and TGF-β2 in hippocampal vs. cerebellar cultures.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
2.3. Additional data 
Transfection studies and different in vitro periods 
(Results obtained by the authors related to the present chapter) 
 
 2.3. Additional data 
 
Transfection studies and different in vitro periods 
 
Results from transfection of cells with a dominant negative form of TGFβ receptor or 3TP-Luc and data from 
immunofluorescent staining of primary cerebellar cultures from P7 rats, maintained in vitro for various periods. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A, B: primary hippocampal cells; C-E: Hib5 cell line. 
A. Transfection of cells with a dominant negative form of TGFβ receptor II (∆TβRII) before treatment with 
CMCerebellum resulted in a significant increase in proliferation, as compared to transfection with TGFβ receptor II 
(TβRII). Similarly, transfection with a dominant negative form of TrkB (∆TrkB) stimulated BrdU incorporation 
after treatment with CMCerebellum; in the latter experiment, EGFP was used as a transfection control. B. Results from 
measurements of MAP2 expression in cultures treated as described in A, show that inhibition of expression of TβRII 
or TrkB prevents CMCerebellum-induced neuronal differentiation. C. HiB5 cells were transfected with the 3TP-Luc 
(Smad pathway) reporter gene and either ∆TβRII or ∆TrkB. Under basal conditions, luciferase activity was inhibited 
significantly in the presence of both dominant negative constructs. D. In a similar experimental design to that shown 
in C, the ability of CMCerebellum to transactivate 3TP-Luc in the presence of ∆TβRII is significantly reduced vs. 
control, whereas in the presence of  ∆TrkB there is no significant effect as compared to control. E. Cells were 
transfected with 3TP-Luc and either TβRII or ∆TβRII before exposure to control or CMCerebellum; results again show 
that functional TβRII is necessary to see CMCerebellum activation of the Smad pathway. 
 
  
 
 
 
Results from immunofluorescent staining of primary cerebellar cultures from P7 rats, maintained in vitro for 
various periods. A, B show relative numbers of TGFβ2- and Math1-positive cells, respectively, during the 
course of culture. C, D show results of BrdU incorporation studies and MAP2 immunostaining in cultures (8 
DIV) exposed for 24h to CM Cerebellum obtained from cerebellar cultures that were 19 DIV.  
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Loss of neurons bearing GR and MR in hippocampus is considered to be a primary cause of disinhibited HPA 
activity. GR activation induces apoptosis of granule cells in the hippocampus. In contrast, neuroprotection is 
seen with MR activation (Hassan et al., 1996; Almeida et al., 2000; Macleod et al., 2003). The opposing 
actions of MR and GR on neuronal survival result from their ability to differentially influence the expression of 
members of the Bcl-2 family of pro- and anti-apoptotic proteins. Specifically, in the rat hippocampus, 
activation of GR induces cell death by increasing the ratio of the proapoptotic molecule Bax relative to the 
antiapoptotic molecules Bcl-2 or Bcl-x(L); the opposite effect is observed after stimulation of MR. In addition, 
GR activation increases and MR activation decreases levels of the tumor suppressor protein p53 (a direct 
transcriptional regulator of bax and bcl-2 genes). Similar findings were obtained in neural cell cultures 
(Crochemore et al., 2002).  
In vivo, the hippocampus receives neural inputs from other cortical and subcortical structures, as well as 
humoral inputs from the periphery which, together complicate analysis of the underlying mechanism of 
glucocorticoid-induced cell death. Previous in vivo studies using the synthetic glucocorticoid dexamethasone 
(DEX) were questioned on the basis that because DEX treatment produces ‘chemical adrenalectomy’ (de Kloet 
et al., 1998); adrenalectomy itself induces apoptosis (Sloviter et al., 1993, Sousa et al., 1997). Moreover, at 
least in mice, P-glycoproteins hinder the access of DEX to the brain (Schinkel et al., 1995; Meijer et al., 1998). 
Further, it was previously shown that aldosterone or low levels of corticosterone can prevent adrenalectomy-
indiced apoptosis, probably by activating MR (Sloviter et al., 1995, Woolley et al., 1991).  
 
The above-summarized problem was resolved in an in vitro model, free from all peripheral influences, namely 
primary hippocampal cell cultures. The results described demonstrate the inherent apoptosis-inducing 
properties of DEX which become better evident if the neuroprotective actions mediated by MR are blocked 
pharmacologically. 
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ALDO     aldosterone 
BSA     bovine serum albumin 
DAB     3,3´-diaminobenzidine tetrahydrochloride 
DEX     dexamethasone 
DIV     days in vitro 
GAPDH     glyceraldehyde-3-phosphate dehydrogenase 
GFAP     glial fibrillary acidic protein 
GR     glucocorticoid receptor 
Hoechst 33342  Phenol, 4-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1H-benzimidazol] 
-2'-yl]-, trihydrochloride 
MAP2     microtubule-associated protein 2 
MR     mineralocorticoid receptor 
SPIRO spironolactone, [7 [alpha ] -(acetylthio)-3-oxo-17 [alpha ] -
pregn-4-ene,21 carbolactone] 
RU28318 Oxprenoate potassium , (7a,17a)-17-Hydroxy-3-oxo-7-
propylpregn-4-ene-21-carboxylic acid, potassium salt 
TdT     terminal deoxynucleotidyl transferase 
TUNEL     TdT-mediated dUTP nick-end labeling 
 Abstract  
An important question arising from previous observations in vivo is whether glucocorticoids can directly 
influence neuronal survival in the hippocampus. To this end, a primary postnatal hippocampal culture system 
containing mature neurons and expressing both glucocorticoid (GR) and mineralocorticoid (MR) receptors was 
developed. Results show that the GR agonist dexamethasone (DEX) targets neurons (MAP2-positive cells) for 
death through apoptosis. GR-mediated cell death was counteracted by the MR agonist aldosterone (ALDO). 
Antagonism of MR with spironolactone (SPIRO) causes a dose-dependent increase in neuronal apoptosis in the 
absence of DEX, indicating that nanomolar levels of corticosterone present in the culture medium which are 
sufficient to activate MR, can mask the apoptotic response to DEX. Indeed, both SPIRO and another MR 
antagonist, oxprenoate (RU28318), accentuated DEX-induced apoptosis. These results demonstrate that 
glucocorticoids can act directly to induce hippocampal neuronal death and that demonstration of their full 
apoptotic potency depends on abolition of survival-promoting actions mediated by MR.  
 Introduction 
Disorders of mood and cognition are linked to hypersecretion of glucocorticoids (GC) resulting from reduced 
efficacy of GC negative feedback.1, 2, 3 One enduring view is that a loss of neurons bearing glucocorticoid (GR) 
and mineralocorticoid (MR) receptors in the hippocampus is the primary cause of disinhibited hypothalamo-
pituiatry-adrenal (HPA) activity; moreover hippocampal cell loss is likely to have repercussions on cognition 
and the regulation of mood and anxiety.  
 
Numerous previous experiments suggest that excessive corticosteroid secretion endangers the survival of 
hippocampal neurons by increasing their vulnerability to concomitant stimuli such as excitatory amino acids, 
calcium influxes and reactive oxygen species.4, 5 The detrimental effects of corticosteroids on the hippocampus 
are backed by imaging studies in humans: there is a strong negative correlation between cortisol levels and 
hippocampal volume in patients with major depression.6, 7 and in subjects with Cushing’s disease;8 reduced 
hippocampal volumes were also recently found in rats treated with dexamethasone (DEX), a GR agonist.9 
While most of the hippocampal shrinkage observed may be due to neuritic atrophy, including dendritic 
impoverishment and synaptic loss,10, 11, 12, other experiments have demonstrated that GR activation activates a 
molecular cascade leading to significant levels of neuronal cell death through apoptotic mechanisms.13 Besides 
apoptosis of mature hippocampal neurons,14 there is also evidence that glucocorticoids interfere with 
proliferation granule neurons of the dentate gyrus.15  
 
MR and GR both bind cortisol/corticosterone, albeit with differing affinities: whereas GR become occupied by 
corticosteroid levels in the high physiological range, MR appear to be tonically active under basal levels of 
HPA activity and there is evidence that activity of the two receptors is coordinated so as to maintain 
endocrinological and behavioral balance.1, 16, 17 We previously proposed that the relative occupation of MR and 
GR also contributes to maintenance of hippocampal cell numbers, since activation of MR counteract 
deleterious glucocorticoid actions on neuronal survival.11, 13, 14 Indeed, the results of earlier studies suggest that 
MR occupation may be essential for the survival of dentate granule neurons.19, 20, 21  
 
The interpretation of previous data showing that DEX can induce neuronal cell death in animals has been 
questioned on the basis that because DEX poorly penetrates the brain  and produces ‘chemical adrenalectomy’ 
by suppressing pituitary ACTH secretion, the observed cell loss may reflect abolition of MR activation rather 
than a direct effect of GR activation.1 The work reported here re-addresses this issue by using a 
pharmacologically malleable model, namely primary hippocampal cell cultures. Our results demonstrate the 
inherent apoptosis-inducing properties of DEX which become better evident if neuroprotective actions 
mediated by MR are blocked.  
 Materials and Methods 
Experiments on animals were conducted in accordance with the European Communities Council Directive No. 
86/609/EEC and local regulations. Hippocampal tissue was obtained from male rat pups, aged 4-5 days (Wistar 
rats; Charles River, Sulzfeld, Germany). Pilot in vivo studies in rats of this age showed an acute injection of 
DEX (100 µg/kg, i.p.) to result in a 60% increase in apoptotic cells in the hippocampus (measured by TUNEL 
histochemistry) within 24 h.  
Tissue and cell dissociation: Rat pups were rapidly decapitated their brains carefully dissected out and placed 
in ice-cold Neurobasal/B27 solution (Invitrogen, Karlsruhe, Germany). Hippocampi were dissected out and 
freed from meninges and vascular tissue excess under a dissecting microscope, before being sliced (ca. 250 µm 
thick) on a McIlwain tissue-chopper. Slices were briefly washed in ice-cold Neurobasal/B27 medium, 
centrifuged briefly (70 g; 20° C) and resuspended in a solution containing papain; to this end, the Papain 
Dissociation Kit (Worthington Biochemical Corp., Freehold, NJ, USA) was used with some minor 
modifications to the manufacturer’s suggested protocol (see ref. 22). Tissue digests were triturated gently and 
transferred to a medium consisting of Neurobasal/B27 medium, 1% fetal calf serum and 0.2% bovine serum 
albumin (BSA) at 37° C, filtered through a sterile nylon mesh (30 µm pore-size) and centrifuged at 200 g (20° 
C; 5 min.) before resuspension in Neurobasal/B27 medium containing enzyme inhibitor (ovomucoid/0.005% 
DNAse; Worthington). Aliquots of this suspension were run through a 1-step ovomucoid/BSA density gradient 
(centrifugation at 70 g at 20° C for 5 min.), taken up in Neurobasal/B27 medium containing basic fibroblast 
growth factor (bFGF) (10ng/ml), Glutamax I (0.5mM) and kanamycin (100µg/ml) (all from Invitrogen) and 
plated on gelatin/PDL-coated glass coverslips (Superior, Bad Mergentheim, Germany) at a density of 450 + 33 
cells/mm2. Cultures were maintained at 37° C, under 5% CO2 and 99% relative humidity.  
Treatments: Cells were exposed to drugs after 6 days in vitro; exposure to experimental drugs was for 48 h. 
The GR agonist (DEX) was obtained in aqueous form (Fortecortin®, Merk, Darmstadt, Germany) and used at 
doses of either 10-6 M or 10-5 M.  The prototypic MR agonist aldosterone (ALDO) was purchased from Sigma 
(Deisenhofen, Germany) and used at a dose of 10-5 M (survival studies) or 10-8 M (translocation experiments) 
after solution in ethanol. Two MR antagonists were used alone or as co-treatments with DEX: spironolactone 
(SPIRO; Sigma) was used at between 10-9 and 10-5 M after solution in ethanol; oxprenoate (RU28318), 
purchased from Tocris Cookson (Bristol, UK), was used at dose ranging from 10-9-10-5 M after direct solution 
in growing medium. Final ethanol concentrations in medium were 0.01%. In all experiments, the position of 
wells subjected to control or drug treatments was randomized; each experiment was performed on at least 3 
independent occasions. 
Hoechst staining: The total number of cells per unit area was determined by counting fluorescent nuclei 
(Hoechst-stained). Briefly, cells were fixed in ice-cold 4% paraformaldehyde (10 min.), washed in PBS and 
incubated with Hoechst 33342 (1 µg/ml; Molecular Probes, Leiden, The Netherlands) for 45 min. in the dark. 
After rigorous washing (PBS), coverslips were mounted in anti-fading medium before counting using the cell 
counting parameters described below. 
Immunocytochemistry: For characterization of cultures by light microscopy, cells were fixed in ice-cold 4% 
paraformaldehyde (10 min.) and incubatzed with the following primary antibodies: mouse anti-microtubule-
associated protein 2 (MAP2; Roche, Mannheim, Germany; 2 µg/ml), mouse anti-myelin basic protein for 
oligodendrocytes (MBP; Chemicon, Temecula, CA; 1:500) and rabbit anti-glial fibrillary acidic protein 
(GFAP; DAKO, Hamburg, Germany; 1:500). Peroxidase-conjugated antibodies (Sigma) and 3,3´-
diaminobenzidine tetrahydrochloride (DAB; 0.025%; Sigma) were used to visualize immunoreactive elements. 
Specimens were examined on an Olympus BX-60 microscope, video-linked to a computer equipped with 
 image-processing software (ImagePro, Maryland, USA). Cell counts were performed on 10 randomly-chosen, 
equally-sized microscopic fields from 5 coverslips under 400X magnification. Data representing numbers of 
immunolabeled cells are expressed relative to total number of cells labeled with Hoechst dye (see above).  
Electron microscopic analysis: For classical electron microscopic characterization of the cultures, cells were 
fixed in 1% paraformaldehyde/1% glutaraldehyde in 0.1 M phosphate buffered saline (PBS; pH 7.4) for 1 h. 
Thereafter, the cells were treated with 1% osmium tetroxide, dehydrated in a graded series of ethanol and flat-
embedded in Epon resin.23 Serial ultrathin sections were cut on an ultratome  and contrasted with uranyl acetate 
and Reynold’s lead citrate. Ultrastructural evaluation was carried out with a Hitachi transmission electron 
microscope. 
Detection of apoptosis by TUNEL histochemistry: TdT-mediated dUTP nick end labeling (TUNEL) 
histochemistry was performed on 4% paraformaldehyde-fixed cells, as described.14, 24 TdT was purchased from 
MBI Fermentas (Heidelberg, Germany). The above-detailed morphometric procedures were use to quantify 
numbers of apoptotic (TUNEL-positive) as a proportion of Hoechst-stained cells.  
Reverse-transcriptase PCR: To detect GR and MR mRNA transcripts in the cultures, total RNA, free from 
chromosomal DNA contamination, was isolated (RNAeasy kit, Qiagen, Hilden, Germany) and reverse 
transcribed with SUPERSCRIPTTM II RNA H-reverse transcriptase (Life Technologies) using custom-
synthesized oligo-dT12-18 primers (MWG Biotech, Ebersberg, Germany). Published primers25  were used and 
amplication conditions were denaturation for 40 s at 94 C, annealing for 1 min. at 62° C (MR) or 40° C (GR), 
and primer extension for 2 min. at 72° C; optimal amplifications of MR and GR mRNA were achieved after 35 
and 25 cycles, respectively.  
Nuclear translocation of MR and GR: After 6 days in vitro, cells were exposed to either DEX or ALDO (both 
at 10-8 M) for 6 h. Cells were then either prepared for detection of MR and GR by immunofluorescence 
(fixation as before) or Western blotting, using rabbit anti-glucocorticoid receptor (GR; Santa Cruz 
Biotechnology, Heidelberg, Germany; 1:1,500) or rabbit anti-mineralocorticoid receptor (MR; Santa Cruz; 
1:1,500). Fluorescence images from DEX- or ALDO-treated cells were compared to those from non-treated 
cells; the prediction was that receptor immunoreactivity in the treated cells would be predominantly localized 
to cell nuclei. For Western blots, cells were lysed and processed as described previously.26  
Statistics: All numerical data, shown as means + SEM, was subjected to ANOVA and appropriate post-hoc 
analyses (SigmaStat 3). The level of significance was preset at P < 0.05.  
 Results 
Model validation 
Most previous investigations on corticosteroid effects on hippocampal cell survival have been performed in 
adult rats or on embryonic rat hippocampal cell cultures; in the present experiments, hippocampal cell cultures 
were prepared from postnatal rats, aged 4-5 days. Preliminary in vivo studies showed that the hippocampi of 
rats of this age are sensitive to the apoptosis-inducing actions of DEX, showing a 60% increase in cell death 
following an acute injection of the drug (data not shown).  
Cells established dense networks in vitro, with some 25-30% of cells staining positively for MAP-2, a marker 
of mature neurons (Fig. 1a, b) as well as for GFAP (astrocytes; Fig. 1c) and myelin basic protein 
(oligodendrocytes; Fig. 1d). Electron microscopic analysis of the cultures revealed cells that displayed 
morphological features typical of neurons (Figs. 1e-j).  
Consistent with results from in vivo studies,27, 28 cells in culture were seen to express MR and GR mRNA 
(detected by RT-PCR analysis; Fig. 2a) as well as receptor protein (immunofluorescence images in Figs. 2b, c). 
Under basal conditions, MR were localized in both the cytoplasmic and nuclear compartments, probably owing 
to the low levels of cortisol in the medium supplement (B27); treatment with ALDO resulted in a greater 
intensity of immunoreactive signal in the nucleus. In contrast, GR in untreated cells were predominantly 
located in the cytoplasm, and were only found in the nucleus after exposure to DEX. The morphological 
localization of GR was corroborated by evidence obtained by Western blot analysis of cytoplasmic and nuclear 
fractions; Fig. 2d shows that DEX treatment results in a conspicuous re-location of GR from the cytoplasmic to 
the nuclear compartment. Together these data indicate that the receptors expressed in vitro are likely to serve 
their roles as ligand-activated transcription factors. 
DEX induces neuronal cell death in an ALDO-reversible manner  
Treatment of hippocampal cultures with the GR agonist DEX (10-5 M) doubled the relative number of TUNEL-
positive (apoptotic) cells within 48 h (P < 0.05; Fig. 3a). A significant proportion of these apoptotic cells were 
mature neurons, as judged by the reduction in the MAP-2 immunoreactive sub-population (P < 0.05; Fig. 3b). 
Whereas exposure to ALDO (10-5 M) did not affect the incidence of apoptosis or the survival of mature 
neurons, the MR agonist significantly attenuated the apotosis-inducing actions of DEX (P < 0.5; Fig. 3). Thus, 
consistent with our previous findings,13, 14 MR occupation counteracts the actions GR.    
MR antagonism accentuates apoptotic actions of DEX  
Blockade of MR with spironolactone (SPIRO; 10-8-10-5 M), resulted in a dose-dependent increase in levels of 
apoptosis (Fig. 4a). The less-potent MR antagonist oxprenoate (RU28318)29, 30, 31 only stimulated apoptosis 
when used at 10-5M, the highest doses tested (Fig. 4b). The apoptotic actions of SPIRO and RU28318 most 
probably result from their counteraction of the pro-survival effects of the nanomolar (MR-activating) levels of 
corticosterone in the B27/Neurobasal medium; these results indicate that tonic occupation of MR is essential 
for neuronal survival. The view that MR activation promotes cell survival was boosted by the finding that both 
MR antagonists synergized with a sub-optimal dose of DEX (10-6 M; 10-fold lower than the dose used in the 
previous experiment) to induce apoptosis; our observations show that manifestation of the full apoptotic 
potential of GR agonists in vitro can be masked by MR agonists that are inadvertently present in the medium. 
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 Discussion 
While a number of potential molecular mechanisms may be proposed to explain the basis of impaired 
glucocorticoid feedback in the hippocampus, the impact of glucocorticoid-induced destruction of the neural 
substrate mediating this feedback has been a recurring theme in psychoneuroendocrinology over the last 
decade. A series of in vivo studies in rats previously demonstrated that the GR agonist DEX stimulates cell 
death in the hippocampus as well as in other selected brain regions such as the striatum and substania nigra.13, 
14, 32, 33 However, it remains unclear as to whether these effects occur directly or whether gluocorticoids merely 
exacerbate the neurotoxic effects of other more potent insults such as excitatory amino acids and reactive 
oxygen species.34, 35, 36 
 
Direct neural actions of DEX have also been questioned on the basis of data showing that DEX has limited 
access to the brain.1 Observations that adrenalectomy leads to apoptosis in the hippocampus,19, 20, 37 together 
with the fact that DEX treatment leads to a state of ‘chemical adrenalectomy’,1  boost the argument against 
direct effects of DEX on hippocampal cell survival. On the other hand, significant levels of apoptosis can be 
observed within 24 hours of a single injection of DEX,14 whereas the effects of adrenalectomy display different 
temporal and spatial dynamics.37, 38, 39 Further, the apoptotic effects of DEX were shown to be blocked with a 
GR antagonist;32 GR are transcription factors and we previously that their activation by DEX can trigger a 
molecular death cascade in the hippocampus and cell cycle arrest in a neural cell line.13, 26  
 
The issue of whether DEX acts directly on neurons to stimulate their demise cannot be resolved easily in vivo. 
We therefore attempted to address this question in primary neuronal cultures derived from early postnatal rats. 
These cultures were carefully characterized and their suitability for our studies verified, especially with respect 
to ontogeny of elements involved in the regulation and responsiveness of the HPA axis,27, 30, 41 as well as to age-
related differences in the in vivo responses to the cell death-inducing actions of corticosteroids.14, 42 Exposure of 
cultures to DEX at a dose of 10-5 M led to a significant loss of mature (MAP-2 positive) neurons, an event 
accompanied by a significant increase in the incidence of apoptosis. The results obtained in this isolated 
hippocampal neuron model, in which DEX can directly access individual cells, therefore show that DEX has 
the intrinsic potential to induce neuronal cell death, and that its effects occur independently of the HPA axis 
and other confounding factors.  
 
The apoptotic actions of DEX (10-5 M) were shown to be significantly attenuated when the MR agonist ALDO 
(10-5 M) was added to the culture medium. This finding is consistent with previous results obtained in rats.11, 13, 
14 Since ALDO on its own did not alter apoptotic cell and neuronal numbers, our results add currency to the 
view that MR can trigger neuroprotective mechanisms; the latter concept emerged from a number of older 
studies which showed that either ALDO or low, MR-activating levels of corticosterone could prevent or 
reverse adrenalectomy-induced apoptosis.18, 19, 39 Notably, the effects of adrenalectomy cannot be ameliorated 
by the administration of DEX.20, 43  
 
Chemically-defined media of the sort used in these studies have significant advantages over serum-containing 
media. Nevertheless, our experiments were somewhat confounded by the presence of corticosterone 
(nanomolar range, sufficient to activate MR) in the medium. This factor most probably accounts for our 
observation that the MR antagonist SPIRO increased neuronal cell death in a dose-dependent (10-7-10-5 M) 
fashion, although another (weaker) MR antagonist (RU28318) did not alter basal levels of apoptosis. Thehis 
 finding supports the interpretation that tonic activation of MR is essential for the survival of hippocampal 
neurons.  
 
In view of the above results, we hypothesized that blockade of ‘medium-activated’ MR would accentuate the 
effects of GR stimulation; the hypothesis was proven correct by analysis of apoptosis after concomitantly 
treating cultures with either SPIRO or DEX and a sub-optimal dose of DEX: whereas DEX at a dose of 10-6 M 
did not induce cell death, its combination with a range of doses of SPIRO or RU28318 (10-8-10-5 M) 
significantly exacerbated the occurrence of neuronal apoptosis. Besides acting on MR, SPIRO can also 
antagonize androgen and progesterone receptors;44 however, since similar results were obtained with RU28318, 
a drug with greater selectivity for MR, our inference that neuroprotective effects are mediated by MR is 
warranted.  
 
In summary, evidence gained in a cellular model shows that glucocorticoids can lead to hippocampal cell death 
without the participation of other aggravating factors, so long as their effects are not masked by previously 
activated MR. The presented results also bolster the view that hippocampal neuronal survival depends on the 
tonic occupation of MR. Further, insofar that these data demonstrate the opposing roles of MR and GR in 
hippocampal cell survival, they add credibility to the ‘receptor balance hypothesis’ that was generated from 
endocrinological and behavioral studies.1, 17 If glucocortiocid-induced hippocampal cell losses do indeed 
contribute to impaired regulation of the HPA axis, eventually leading to mood, anxiety and cognitive 
impairments, therapeutic tools designed to selectively activate MR or to specifically improve their signaling 
efficiency in neurons45, 46 would be a worthwhile strategy. 
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Figure 1. Immunocytochemical and ultrastructural characterization of primary postnatal rat 
hippocampal cultures.  
 
(a) Low magnification field view of primary rat hippocampal cultures (5 days in vitro), immunostained with 
microtubule-associated protein 2 (MAP2). (b) High power micrography showing differentiated MAP2-
immunolabeled neurons. (c) High-power micrograph of astrocytes immunostained for glial fibrillary protein 
(GFAP). (d) An immunoreactive oligodendrocyte labeled with anti-myelin basic protein. Scale bars represent 
120 µm (a) and 30 µm (b-d). (e) Medium-power electron micrograph of a cultured cell showing typical features 
of a neuron. Note the large nucleus (Nu) within the perikaryon (P) richly endowed with free and membrane–
bound ribosomes. (X10,000). (f) Electron micrograph showing numerous ribosomes (arrow) and cysts of a 
Golgi-complex (arrowhead) within the neuronal cytoplasm (X28,000). (g) Demonstration of a growing 
neuronal process (P) exhibiting bundles of microtubules and mitochondria (X 13,000). (h) High-power view of 
a neuronal process with microtubules organized in a parallel fashion (arrow). Note the association of ovoid 
transit vesicles (arrowheads) with microtubules (X32,000). (i) High power micrograph of an astrocyte with a 
prominent bundle of glial filaments within its cytoplasm (arrows) (X40,000). (j) Example of a neuronal 
perikaryon (P) lying adjacent to a glial process (GP) showing glial filaments (arrowhead). Also shown is a 
neuronal process (NP) growing along the surface of the glial element. The arrow points to a synaptic vesicle-
sized element (X30,000).  
  
 
 
Figure 2. Glucocorticoid (GR) and mineralocorticoid (MR) receptor expression and translocation in 
hippocampal cell cultures. (a) RT-PCR demonstration of MR and GR expression in primary hippocampal 
cultures maintained for 5 days in vitro. The transcript size of each receptor corresponded with previously-
published data.25 (b) Low-power photomicrograph showing neurons displaying GR immunoreactivity. Note 
that the cells were treated with DEX (10-7 M) for 6 h before fixation, and that the GR signal is mainly located in 
nuclei, indicating translocation of the receptor from its normal cytoplasmic (unliganded) location. (Scale bar 
represents 60 µm). (c) High power view of a neuron displaying MR-immunoreactivity in its nucleus following 
exposure to the prototypic MR agonist aldosterone (10-8 M) for 6 h. (Scale bar represents 15 µm). Note that a 
small proportion of neurons and glia displayed MR immunoreactivity in their cytoplasma in the absence of 
exogenous ligand (data not shown), probably owing to the low concentrations of cortisol present in the growing 
(B27) medium. (d) Further demonstration (Western blot) that DEX treatment (10-6 M) mobilizes 
immunoreactive GR to the nucleus.  
 
 Figure 3. Opposing effects of GR and MR ligands on hippocampal neuron  
 
survival. (a) In contrast the effects of the MR agonist aldosterone (ALDO;10-5 M), the GR ligand 
dexamethasone (DEX; 10-5 M) induces significant levels of apoptosis in hippocampal cultures. The apoptotic 
potential of DEX is significantly attenuated when cultures are concomitantly treated with ALDO and DEX. (b) 
The size of the neuronal (MAP-2 positive) subpopulation of cells in the cultures is significantly reduced in the 
presence of DEX (10-5 M) and unaffected by ALDO (10-5 M); the number of MAP-2 positive neurons is not 
significantly different from that observed in controls when cultures are exposed both ALDO and DEX. It is 
inferred from the mirror images of the data shown in (a) and (b) that DEX targets neurons for apoptotic death 
in an ALDO-reversible manner.  
  
 
Figure 4. Blockade of MR compromises neuronal survival and predisposes neurons to DEX-induced 
apoptosis. As compared to the previously used dose of dexamethasone (DEX;10-5 M; Fig. 3), a ten-fold lower 
dose of the GR agonist does not cause significant apotosis in hippocampal cultures (cf. second and third bars in 
a and b). Reasoning that this may have resulted from nanomolar (MR-activating) concentrations of  levels of 
corticosterone in the culture medium, cells were exposed to two MR antagonists, spironolactone (SPIRO; a) 
and RU28318 (b); these compounds display slightly different pharmacological profiles.29, 30, 31 In the absence of 
dexamethasone (DEX), addition of SPIRO (10-8-10-5 M) dose-dependently increased the incidence of apoptosis 
(a); RU28318 at a dose of 10-5 M also significantly stimulated apoptosis (b). In combination with the apoptosis 
non-inducing dose of DEX (10-6 M; a and b), all doses of SPIRO and RU28318 led to levels of cell death that 
were significantly greater than those seen after treatment with the antagonist alone, i.e. blockade of MR with 
either SPIRO or RU28318 increased neuronal sensitivity to the apoptotic actions of DEX.  
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Glucocorticoid-induced neuronal apoptosis: sparing of immature 
neurons and sacrifice of mature neurons 
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 3.3. Additional data 
 
Glucocorticoid-induced neuronal apoptosis: sparing of immature neurons and sacrifice of 
mature neurons 
Immature and mature (post-mitotic) neurons can be distinguished using immunochemical markers. Anti-nestin 
labels neuronal prercursors, whereas anti-doublecortin (DCX) labels neruroblasts (early postmitotic neurons) 
and anti-MAP-2ab and anti-NeuN label mature neurons. In addition, astrocytes can be stained with anti-GFAP. 
These markers were used to address the following question in primary postnatal hippocampal cultures: does 
glucocorticoid treatment target immature or mature neurons for apoptosis? This question deserves attention in 
view of data showing that dexamethasone (DEX) kills ‘hippocampal cells’, while at the same time reductions 
in neurogenesis seen after exposure to stress may be attributed to the elevated levels of corticosteroids 
experienced during and after a stressful stimulus. In these experiments, analysis was facilitated by including a 
pharmacological inhibitor of mitosis, arabosinide-C (Ara-C).  
  
GR antagonists RU38486 and J2700, as well as geldanamycin (gel, an inhibitor of the heat shock protein 90 
GR chaperone) attenuate DEX-induced apoptosis in hippocamapl primary cultures. 
 
 
 
  
Semi-quantitative chemo-phenotyping of primary hippocampal cultures using various markers (Nestin 
for neural precursors, Doublecortin for neuroblasts, TuJ1 for early-mature neurons, MAP2 and NeuN for 
mature neurons, and GFAP for astroglial cells).  
  
Change in relative numbers of cells displaying various phenotypes after treatment with DEX. 
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 4.1. Supplementary background information 
 
Activation of glucocorticoid receptors (GR) leads to neuronal atrophy and death, a phenomenon that has been 
linked to disorders of mood and cognition as well as neuroendocrine dysregulation (Abraham et al., 2001; 
Sousa and Almeida, 2002). Our previous studies have clearly demonstrated that glucocorticoid-induced cell 
death in the hippocampus is apoptotic in nature as judged by morphology and the involvement of specific 
genetic programmes (Almeida et al., 2000). Several different, although not mutually exclusive, mechanisms 
have been implicated in these GR-mediated neurodegenerative effects; these include reduced glucose uptake by 
neurons, increases in the extracellular concentrations of glutamate with concomitant elevations in intracellular 
Ca2+ levels (Sapolsky, 2000).  
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 General Discussion 
A central problem in developmental neurobiology concerns how the balance between neuronal birth, 
differentiation and death are maintained in the CNS, what factors and regulatory mechanisms might be 
involved in these processes, and how neuronal development is co-ordinated spatially and temporally. These 
questions formed the basis of the work reported in this thesis.  
 
Primary hippocampal granule cell cultures were used to mimic the early postnatal period when the transition 
from high proliferation to differentiation occurs (i.e. when the subgranular layer [SGZ] begins to appear); this 
period represents a critical developmental window when pro-neuronal factors increase and pro-proliferation 
factors decrease, as well as a time when program cell death is prominent. Also used were slightly older 
cerebellar granule cells cultures originating from animals in which the external granular layer (EGL) had begun 
to disappear. Together, these model systems served to investigate the regulation of proliferation and neuronal 
differentiation by secreted growth factors, glucocorticoids and NMDA. Attempts were also made to understand 
the underlying molecular mechanisms of these processes. Although not directly addressed in the main work 
presented here, the importance of spatial arrangements is illustrated in the results described in Appendix 1 
based on an in vivo study on the rat hippocampus.  
 
5.1. Experimental approaches 
In order to facilitate analysis of the factors and mechanisms regulating neuronal development, experiments 
were carried out using in vitro models: primary dissociated hippocampal and cerebellar cell cultures, 
hippocampal and cerebellar slice cultures, and a neural cell line (HiB5) derived from hippocampal progenitor 
cells. Depending on the specific question being addressed, the primary cell and slice cultures were obtained 
from rats of different postnatal developmental stages. While more amenable to genetic manipulations and 
pharmacological treatments, and providing for convenient replication of experiments in a given set of neural 
phenotypes under controlled environmental conditions, these model systems have a number of obvious 
limitations however. Primary concerns associated with such systems is the lack of the neural matrix found in 
vivo, and the high likelihood that the intercellular connections seen do not faithfully represent those found in 
situ; the latter problem may be accentuated by the fact that mature neurons are less likely to survive the 
dispersal and cultivation conditions than immature ones. Further, at least with respect to the dissociated cell 
cultures, between-experiment reproducibility can be easily compromised by variations in the starting quality 
and cellular composition (e.g. relative numbers of neurons to glia, progenitor versus mature neurons) of the 
cultures. In light of these reservations, it is essential that extrapolations from the situation in vitro to that in vivo 
be made with extreme caution.  
 
Immunohistochemical detection of cells incorporating the thymidine analogue, bromodeoxyuridine (BrdU), 
served to gain an insight of cell proliferation in the studies described here. This widely used method is more 
convenient than the traditional one involving the labelling of cells with 3H-thymidine, but is associated with the 
risk of detecting cells entering apoptosis unless it is used with extreme caution (e.g. discarding BrdU-labeled 
cells showing nuclear condensation and fragmentation and membrane blebbing). In some instances, mitosis 
was confirmed with the aid of Hoechst 33342 dye which exclusively labels DNA, allowing the identification of 
cell nuclei.  
 
 Neurons, in various stages of maturity were identified immunocytochemically with the aid of specific antisera. 
Immature neurons (neuroblasts) were marked with anti-doublecortin, anti-TuJ1, anti-MASH and anti-Math1, 
whereas mature neurons were marked with anti-MAP2a,b. The majority of non-neuronal cells in cultures 
showed the morphological characteristics of astro-glial cells, and were labelled with anti-GFAP.  
 
Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) was used to detect apoptotic cells. 
Appendix 2 provides a detailed critique of the various methods available to detect apoptosis; despite several 
reservations, TUNEL still remains the most reliable and commonly-used method for detection of apoptosis. 
 
Appendix 2 also includes a discussion about methods for the quantification of cell numbers in a given 
physiological state, using stereological tools. The latter, which are easily applied to histological sections were 
not used in the cell-based studies described in the main work described here. Rather, we resorted to a variation 
of the Abercrombie counting method, and data are usually presented with respect to total number of cells in 
several randomly-chosen, but representative, microscopical fields. 
 
Both pharmacological and gene transfection approaches were applied to identify some of the mechanisms 
controlling neuronal birth, maturation and death. Transfections were done using a non-viral approach, mainly 
with the help of Lipofectamine 2000™ and, in some cases, the cationic polyethylenimine (PEI). The precise 
conditions and ratio of DNA:transfectant was carefully determined for primary neurons, assuring good survival 
of cultures and with a reasonable rate of transfection (ca. 5%) which provided reliably quantifiable results 
(counts of green fluorescent protein (GFP)-labeled cells, translocation of GFP-fused proteins from the 
cytoplasm to nucleus, and reporter gene assays).  
 
5.2. Endocrine and paracrine factors in neural development 
As described in the General Introduction (Chapter 1), neural development is regulated by temporally and 
spatially differentially distributed factors, including intrinsic factors like bHLH transcription factors (eg. 
Mash1, Math1, NgN), cell cycle regulators (e.g. p21, p27, p57) and extrinsic factors like neurotransmitters such 
as glutamate, cytokines (e.g. TGFβ, BMP), neurotrophins (e.g. BDNF, NGF), and hormones (e.g. 
glucocorticoids). The neurotransmitters, cytokines and neurotrphins mainly function by autocrine or paracrine 
mechanisms via membrane receptors, whereas glucocorticoid action are mediated by nuclear receptors; all of 
these extrinsic signals can trigger a cascade of responses resulting in the induction of proliferation, 
differentiation and apoptosis (or survival) by the intrinsic factors. The pro-neural proteins (eg. Mash1, Ngn2) 
can promote neuronal differentiation by downregulating the cell cycle by activating expression of cdk 
inhibitors (e.g. p27, p21, p57) or by  upregulating the expression of neuronal differentiation genes (e.g. 
NeuroD) and inhibiting gliogenic factors (e.g. LIF, CNTF, BMP) (Bertrand et al., 2002). For example, p27 
promotes gliogenesis in the absence of co-expressed bHLH proteins (Ohnuma et al., 2002) and neurotrophins 
facilitate neuronal differentiation by inducing the expression of Mash1 and Math1 (Ito et al., 2003); BMP2/4 
and epidermal growth factor (EGF) were shown to decrease expression of the pro-neural molecule Mash1 
(Ahmad et al., 1998; Shou et al., 1999); the mGlu5 receptor is present in zones of active neurogenesis (e.g. 
such as the cerebellar EGL and hippocampal SGZ) – mGlu5.R expression is highest during the first postnatal 
week (Di Giorgi Gerevini et al., 2004), correlating with high levels of neurogenesis and glutamate release and 
probably involving calcium activation of cell cycle inhibitors (Benitez-Diaz et al., 2003). Taken together, 
neural development is highly programmed with highly temporally and spatially coordinated interactions 
 between intrinsic and extrinsic factors - increased production of specific neurotrophins or neurotransmitters 
appear to increase pro-neural transcription factors and cell cycle inhibitors which, in turn, enhance other pro-
neural factors and decrease pro-proliferation factors. 
 
Although many studies have addressed the above-mentioned neuronal development pathways, little is known 
about the interactions between neurotrophins, cytokines, neurotransmitters and hormones in the regulation of 
proliferation, differentiation, survival and death. The many similarities between hippocampal and cerebellar 
granule cells raise interesting questions about the timing of the disappearance of the EGL and appearance of the 
neurogenic SGZ; are these areas controlled by common intrinsic and extrinsic factors and, if so, what is their 
identity, and what mechanisms do they exploit? This study focussed on candidate extrinsic factors, in particular 
glucocorticoids, NMDA, BDNF and transforming growth factor β2 (TGFβ2).   
 
Interactions between glucocorticoid and several growth factors have been previously described. For example, 
glucocorticoid treatment increases NGF, NT-3, trkA, trkB, trkC and bFGF mRNA expression (Roskoden et al., 
2004), although the same treatment decreases proliferation of hippocampal and cerebellar granule cells and 
promotes premature cessation of precursor cell formation in the EGL (see Table 3 in General Introduction). In 
contrast, adrenalectomy decreases NGF, BDNF and NT-3 mRNA expression (Barbany and Persson, 1992), and 
enhances cell proliferation and delays disappearance of EGL in cerebellum while promoting hippocampal 
granule cell birth (Table 3 in General Introduction). One open question with respect to these studies is whether 
glucocorticoids exert their anti-proliferative actions by activating pro-neural factors or by direct influences on 
regulators of the cell cycle.  
 
Glucocorticoid actions are mediated by two nuclear receptors, mineralocorticoid (MR) and glucocorticoid (GR) 
receptors. Whereas activation of MR or blockade of GR promotes cell survival, activation of GR or antagonism 
of MR leads to hippocampal granule cell death. As already described in the General Introduction (Chapter 1), 
GR activation upregulates the expression of NMDA.R, which are strongly implicated in neurotoxicity (Weiland 
et al., 1997). At the same time, GR occupation is associated with increased glutamatergic transmission 
(Moghaddam et al., 1994) and glutamate facilitates GR activation (Gursoy et al., 2001). These observations 
indicate intricate interactions exist between glucocorticoids and glutamate receptors; however, little is known 
regarding the mechanisms of these interactions. Important questions which arise include: can glucocorticoids 
potentiate NMDA-induced cell death? Do glucocorticoids induce hippocampal cell death through the mediation 
of glutamate receptors?  Also, which cells are targeted for death by glucocorticoids – immature or mature cells? 
Answers to these and the previously-raised questions were sought during the course of this work using 
dissociated hippocampal and cerebellar cell culture models. Cells from 4-7 day old rats were cultured for 7-14 
days in vitro, thus covering time windows when the hippocampal SGZ was just beginning to develop and when 
the cerebellar EGL was beginning to disappear. Consistent with the previously-described different 
developmental profiles of hippocampal and cerebellar granule neurons, cerebellar cultures contained a greater 
percentage of mature cells, as judged by the expression of MAP2ab. 
 
A. Cytokine regulation of cell birth and differentiation  
To study whether secreted growth factors that might contribute to the temporally distinct patterns of 
hippocampal and cerebellar granule cell development, conditioned medium (CM) exchanges between 
hippocampal and cerebellar cultures were used in the experiments described in Chapter 2. Interestingly, 
 CMHippocampus stimulated proliferation in cerebellar cultures whereas CMCerebellum treatment inhibited cell 
proliferation and accelerated neuronal maturation in hippocampal cultures. The latter events were accompanied 
by increased expression of two cell cycle arrest-related molecules, p21 and p27. Results of subsequent antibody 
neutralization experiments indicated that the anti-proliferative actions of CMCerebellum  may be due to the 
presence of BDNF, TGFβ2 and BMP2; involvement of these molecules was confirmed by molecular pathway 
analysis (described in the  next section). Ongoing experiments are using slice-slice and slice-cell co-cultures to 
obtain further evidence for this. In addition, a newly-developed slice-membrane blotting technique is being set 
up to investigate whether BDNF and TGF-β2 are found within or in the close vicinity of cerebellar and 
hippocampal granule cell layers; such evidence would strongly suggest that these factors act in a paracrine or 
even autocrine mode.  
 
Neurotrophins such as BDNF and NGF exert their actions on neuronal survival and differentiation by signaling 
through TrK receptors (Hofer et al., 1990; Minichiello and Klein, 1996; Borghesani et al., 2002; Bandtlow et 
al.,1990; von Bartheld, 1991; Rocamora et al., 1993; Segal et al.,1995; Zhou and Rush, 1994) which are linked 
to the activation of Ras-Raf-MAPK pathways. In general, neurotrophins stimulate rather than inhibit 
proliferation (see Table 1 in General Introduction) and promote neuronal differentiation (Benraiss et al., 2001; 
Chmielnicki and Goldman, 2002); here, treatment of immature cells with BDNF was found to inhibit 
proliferation (Chapter 2), and effect that might be related to the observation that BDNF induces p21 expression 
in maturing cerebellar granule cells (Lin et al., 1998).  
 
There are three isoforms of TGF-β, each derived from separate genes: TGF-β1 whose expression is normally 
restricted to the choroid plexus, and TGF-β2 and TGF-β3 which are expressed in neurons and glia (Unsicker et 
al., 1991; Pratt and McPherson, 1997). TGF-β1 and TGF-β3 have been implicated in neuroprotection, while 
neurotrophic functions have been ascribed to TGF-β2 and TGF-β3 (Finch et al., 1993; Böttner et al., 2000; 
Pratt and McPherson, 1997). The latter include stimulation (Mahanthappa and Schwarting, 1993) or inhibition 
(Constam et al., 1994) of neurogenesis, or both (Kane et al., 1996), as well as the regulation of neuronal 
differentiation (Ishihara et al., 1994; Abe et al., 1996; Cameron et al., 1998). TGF-β2, the isoform focused on 
in this work, is expressed in the EGL (neurogenic) and in Purkinje and radial glia of the cerebellum according 
to a strict temporal pattern but  interestingly,  appreciable levels of TGF-β2 are not seen in other brain sites of 
neuronal proliferation (Flanders et al., 1991; Constam et al., 1994; Unsicker and Strelau, 2000). The 
previously-described expression profiles held true in our cultures: TGF-β2 was much stronger in cerebellar vs. 
hippocampal cells (Chapter 2). Ongoing immunostaining to examine the dynamics of BDNF and TGFβ2 
expression in the cerebellum and hippocampus of postnatal rats suggests that the temporal profiles of 
expression of these two peptides place them in a good position to block proliferation and induce maturity in 
granule cells from both the cerebellum and hippocampus. Although not tissue-specific these molecules reflect 
the temporal co-ordination of ligand availability and signaling cascades in two cell types each displaying its 
unique developmental time-table.  
 
The studies described in Chapter 2 demonstrated important roles for BDNF and TGF-β2 in the maturation of 
cerebellar and hippocampal granule cells; pilot studies (not presented) have also implicated bone 
morphogenetic protein-2 (BMP2). While ontogenetic maps and mechanisms of action (see next section) are 
available for each of these factors, the question arises as to why several factors apparently share in the same 
function? Is it likely that each extrinsic factor is specifically responsible for the maturation of definitive 
 neuronal phenotypes that could not be identified by our cell characterization tools? Do all these factors belong 
to an evolutionarily conserved pool where individual factors can compensate for each other, or are there cross-
talk between these factors directly or at the level of signal transduction? This last point is addressed later in this 
Discussion.  
 
B. Glucocorticoid receptors: maintaining the balance between hippocampal survival and death 
The results described in Chapter 3 deal with the role of MR and GR in maintaining the balance between cell 
survival death through apoptosis. A series of in vivo studies in rats previously demonstrated that the GR agonist 
dexamethasone (DEX) stimulates cell death in the hippocampus as well as in other selected brain regions such 
as the striatum and substania nigra (Hassan et al., 1996; Almeida et al., 2000; Haynes et al., 2001). However, it 
remains unclear as to whether these effects occur directly or whether gluocorticoids merely exacerbate the 
neurotoxic effects of other more potent insults such as excitatory amino acids (Elliott et al., 1993) and reactive 
oxygen species (Behl et al., 1997). Direct neural actions of DEX have also been questioned on the basis of data 
showing that DEX has limited access to the brain (de Kloet et al., 1975; Schinkel et al., 1995; Meijer et al., 
1998). In addition, observations that adrenalectomy (ADX) leads to apoptosis in the hippocampus (Sloviter et 
al. 1993; Sousa et al., 1997), together with the fact that, by suppressing adrenocortical secretion, DEX 
produces ‘chemical adrenalectomy’ boost the argument against direct effects of DEX on hippocampal cell 
survival. It should be noted however, that the mechanisms underlying ADX- and DEX-induced apoptosis are 
likely to be distinct since whereas significant levels of apoptosis can be observed within 24 hours of a single 
injection of DEX (Hassan et al., 1996), the effects of adrenalectomy display different temporal and spatial 
dynamics (Jaarsma et al., 1992; Hu et al., 1997; Sousa et al. 1997). Further, the apoptotic effects of DEX were 
shown to be blocked with a GR antagonist (Haynes et al., 2001). As mentioned earlier, GR are nuclear 
receptors which act as potent transcription factors; previous work from this laboratory showed that DEX can 
trigger a molecular death cascade in both the hippocampus (Almeida et al., 2000) and a neural cell line 
(Crochemore et al., 2002). 
 
To address the specific question of whether DEX treatment directly causes apoptosis in the hippocampus, we 
here used primary hippocampal cultures which we demonstrated to express both MR and GR. The experiments 
were aided by the following pharmacological tools: the MR agonist aldosterone (ALDO), the MR antagonists 
spironolactone (SPIRO) and RU28318 (oxprenoate), and the GR agonist DEX. Exposure of cultures to DEX at 
a dose of 10-5 M led to a significant loss of mature (MAP-2 positive) neurons, an event accompanied by a 
significant increase in the incidence of apoptosis. The results from these studies involving a system in which 
DEX can directly access hippocampal cells, therefore demonstrate that DEX has the intrinsic potential to 
induce neuronal cell death, and that its effects occur independently of the HPA axis and other confounding 
factors. Consistent with previous results which suggested that low, MR-activating doses of corticosterone in 
rats (in vivo) may be neuroprotective (Hassan et al., 1996; Sousa et al., 1999; Almeida et al., 2000), it was 
observed here that the apoptotic actions of DEX could be significantly attenuated when the MR agonist ALDO 
(10-5 M) was added to the culture medium. Since ALDO on its own did not alter apoptotic cell and neuronal 
numbers, our results add currency to the view that MR can trigger neuroprotective mechanisms; this 
interpretation is supported by reports from other laboratories that either ALDO or low levels of corticosterone 
prevent or reverse ADX-induced apoptosis (Woolley et al., 1991; Sloviter et al., 1993; Hu et al., 1997). In light 
of the results showing the ability of ALDO to counteract the apoptotic actions of DEX, and the fact that our 
culture medium contained low levels of cortisol (which has pharmacological properties and biological actions 
 which are comparable to those of corticosterone), it was hypothesized that the blockade of ‘medium-activated’ 
MR would accentuate the effects of GR stimulation. Analysis of apoptosis after concomitantly treating cultures 
with either SPIRO or RU28318 and a sub-optimal dose of DEX (10-6 M) proved our hypothesis correct – 
whereas DEX at a dose of 10-6 M did not induce cell death, its combination with a range of doses of SPIRO or 
RU28318 (10-8-10-5 M) significantly exacerbated the occurrence of neuronal apoptosis. Besides acting on MR, 
SPIRO can also antagonize androgen and progesterone receptors (Nirdé et al., 2001); since similar results were 
however obtained with the more receptor-selective drug RU28318, the inference that neuroprotective effects 
are mediated by MR appears to be warranted.  
 
Together, results obtained using a cellular model provide clear evidence that glucocorticoids can lead to 
hippocampal cell death without the participation of other aggravating factors (e.g. excitotoxins), so long as 
their effects are not masked by previously-activated MR. The presented results also bolster the view previously 
advanced by this laboratory that hippocampal neuronal survival depends on the tonic occupation of MR, and 
exemplify that the ‘receptor balance hypothesis,’ originally generated on the basis of endocrinological and 
behavioral data (de Kloet et al., 1998), can be extended to include hippocampal survival and death.  
 
C. NMDA regulation of neuronal survival vs. death depends on site of action of NMDA  
As mentioned in the General Introduction (Chapter 1), glucocorticoids and GluR share an intimate relationship. 
Previous work showed that GluR stimulation can result in excitotoxicity and that the latter can be amplified by 
pre-treatment with glucocorticoids (Goodman et al., 1996; Behl et al., 1997; Abraham et al., 2001; Johnson et 
al., 2002) prompted us to examine the effects of NMDA pre-treatment on DEX-induced apoptosis (Chapter 4). 
To do this, we treated hippocampal cultures with NMDA at doses ranging from 1 to 10 µM for a brief period 
(15 min) before exposure to DEX (1 µM) for 72 h. We observed a complete abolition of the apoptotic actions 
of DEX when cells were pre-exposed to NDMA at 1 and 5 µM; at a dose of 10 µM, NMDA resulted in a rapid 
necrotic response.  
 
The NMDA.R represents the most-intensely studied GluR, especially in the context of neurotoxicity. These 
receptors are heteromeric in nature, consisting of a common NR1 subunit and one or more NR2 subunits 
(NR2A-D), whose insertion in the NMDA.R complex varies during development and maturity of synapses (Li 
et al., 1998; Stocca and Vicini, 1998; Tovar and Westbrook, 1999). For example, it is known that whereas 
NR2A is predominantly found in NMDA.R located at the synapse, NR2B features almost exclusively in 
NMDA.R at extrasynaptic (non-synaptic) sites. An important concept that has emerged from recent studies is 
that synaptic NMDA.R can initiate neuroprotective mechanisms; in contrast, activation of extrasynaptic 
NMDA.R results in cell death (Hardingham et al., 2002). The results reported in Chapter 4 demonstrate that 
selective inhibition of NR2B with ifenprodil results in a suppression of DEX-induced apoptosis; this finding is 
consistent with the documented efficacy of ifenprodil in retarding cell death in various animal models of 
neurodegenerative disease (for review, see Chenard and Menniti, 1999). Thus, blockade of extrasynaptic 
NMDA.R can counteract the apoptotic actions of glucocorticoids.  
 
In addition to the above experiments, studies of the other important ionotropic glutamate receptor AMPA.R 
were also undertaken. Selective blockade of AMPA.R with NBQX also proved effective at attenuating DEX-
induced apoptosis in hippocampal cultures. Further, the present studies revealed a role for metabotropic 
glutamate receptors (mGluR) insofar that E4CPG and CPPG, selective antagonists of mGluR I/II and II/III, 
 respectively, were able to rescue hippocampal cells from DEX-induced apoptosis at very low doses. In general, 
the manifestations of mGluR-mediated actions are slow and involve gene activation. Type I mGluR have been 
associated with neuronal death while Type II/III mGluR have been shown to contribute to neuronal survival 
(Snyder et al., 2001; Allen et al., 2001; Miskevich et al., 2002; Heidinger et al., 2002). Together, these findings 
suggest the involvement of either complex regulatory interactions between the various mGluR or the 
upregulation of neurotoxic type I mGluR by DEX.  
 
The results reported in this section represent the first attempt to understand the mechanistic and functional 
nature of interactions between GluR and glucocorticoids. They demonstrate that the apoptotic actions of DEX 
are at least partly mediated by GluR of the NMDA and metabotropic types. In addition, the results reported 
herein show that low doses of NMDA, acting via synaptic NMDA.R can effectively block hippocampal cell 
death induced by DEX. Lastly, this work indicates that glucocorticoids can cause apoptosis in hippocampal 
cells by triggering rapid (NMDA.R-mediated) as well as slow (mGluR- or GR-mediated) responses, and that 
the final outcome of glucocorticoid treatment on hippocampal cell survival depends on the convergence and 
integration of transcriptional signals (e.g. GluR and agonist availability; regulation of apoptosis-related genes) 
and signals originating at the cell membrane (e.g. Ca2+ conductance). 
 
5.3. Mechanisms underpinning glucocorticoid, NMDA and cytokine actions on neural 
development and survival 
A. Glucocorticoid-glutamate interactions 
Glucocorticoids can exert rapid, transient effects on neuronal excitability involving increased cytosolic 
concentrations of Ca2+ (Nair et al., 1998). However, glucocorticoid actions are best known to be mediated 
through GR which are transcription factors; our laboratory has previously elucidated some of the cell death-
related molecular pathways triggered by exposure to the potent GR agonist DEX (Almeida et al., 2000). Thus, 
glucocorticoid effects on hippocampal structure and function do not necessarily result from one exclusive 
mechanism (electrophysiological vs. genomic) but may rather occur as a result of integrated signals arising 
from both the cell membrane and transcriptional activity. For example, by influencing the transcription of Ca2+ 
channel and Ca2+ extrusion pump genes (Bhargava et al., 2000), glucocorticoids contribute to long-term 
alterations in the dynamics of intracellular Ca2+ levels, including those originating at the plasma membrane 
(Kerr et al., 1992; Elliott and Sapolsky, 1993; Nair et al., 1998; Bhargava et al., 2000).  
 
Exaggerated and chronic elevations in intracellular Ca2+ accompany glutamatergic excitotoxicity (Choi, 1991; 
Coyle and Puttfarcken, 1993) and have also been proposed to at least partially underlie the neurotoxic effects of 
glucocorticoids (Joëls, 2001). Increases in cytosolic Ca2+ concentrations result from the activation of both 
ionotropic glutamate receptors (iGluR) and mGluR, albeit through different mechanisms: iGluR stimulate the 
influx of Ca2+ from the extracellular space, whereas mGluR mobilize Ca2+ from intracellular reservoirs (Maiese 
et al., 1999; Otani et al., 2002). As mentioned before, glucocorticoids can increase NMDA.R expression and 
glutamate synthesis and accumulation (Weiland et al., 1997; Moghaddam et al., 1994), and potentiate 
glutamate-induced cell death (Goodman et al., 1996; Behl et al., 1997; Abraham et al., 2001; Johnson et al., 
2002). GluR are well-recognized triggers of neuronal cell death and may occur either acutely upon activation or 
after a period of delay (Choi, 1991). Apoptotic and necrotic cell death are distinguishable on the basis of their 
morphological characteristics and ionic dependence. The rapid-onset form is necrotic in nature (cell swelling 
and ultimate cell lysis). In contrast, the delayed form is Ca2+-dependent, and is accompanied by cell shrinkage, 
 nuclear condensation and fragmentation; all of the latter features are typical of apoptosis (Choi, 1991). In the 
work described in Chapter 4, the dominant form of cell death observed following treatment of hippocampal 
cells with either NMDA or DEX was of the apoptotic type.  
 
On the other hand, low doses of NMDA have been shown to elicit neurotrophic and anti-apoptotic mechanisms 
in neurons (Marini et al., 1998; Resink et al., 1996; Brandoli et al., 1998); moreover, one of the implicated 
neurotrophins, brain-derived nerve growth factor (BDNF), was found to stimulate (pro-survival) NR2A subunit 
expression and to suppress NR2B (death-promoting) expression (Glazner and Mattson, 2000). Because the 
experimental paradigm used in Chapter 4 involved chronic exposure to DEX, it is pertinent to mention that GR 
activation was previously found to upregulate NR2B subunit gene expression with a concomitant decrease in 
the expression of the gene encoding NR2A subunit (Nair et al., 1998).  
 
As noted above, NMDA.R which include the death-promoting NR2B subunit are predominantly localized at 
extrasynaptic sites; in contrast those comprising the pro-survival NR2A subunit have a synaptic location 
(Riccio and Ginty, 2002). Since the appearance of NR2A- and NR2B-containing NMDAR is correlated with 
the ontogeny of synapses (Tovar and Westbrook, 1999; Li et al., 1998; Stocca and Vicini, 1998), it is pertinent 
to note that although the  cultures used for the present studies were relatively young (experiments carried out 
after 6 days in vitro), cell-cell interactions were abundantly evident at the light microscopic level. In order to 
distinguish between synaptic and extrasynaptic NMDA.R in the mediation of the protective actions of low 
doses of NMDA against DEX-stimulated apoptosis, the recently described elegant pharmacological paradigm 
described by Hardingham et al. (2002) was adopted. Briefly, the paradigm which consists of briefly (15 min.) 
pre-treating  hippocampal cultures with the GABA antagonist bicuculline (to activate synaptic GluR) and 
MK801 (to block active NMDAR) prevents NMDA activation of neuroprotective signaling cascades, leaving 
only extrasynaptic NR2B-containing NMDAR available for NMDA binding. In the studies described in 
Chapter 4, bicuculline/MK801-pretreated cultures were exposed to 1 or 5 µM NMDA and DEX before analysis 
of apoptosis using the TUNEL assay. The observation that the bicuculline/MK801 pre-treatment abrogated the 
ability of NMDA to oppose the apoptotic actions of DEX is consistent with a synaptic site of NMDA-induced 
neuroprotection (Hardingham et al., 2002).  
 
In an experiment to examine the impact of NR2B subunit-containing NMDAR blockade on the neuroprotection 
afforded by low doses of NMDA against DEX-elicited apoptosis, NR2B blockade was achieved by pre-treating 
cells with NMDA and ifenprodil (Chapter 4). The rationale was that this design would ensure binding of 
ifenprodil (an activity-dependent antagonist), to extrasynaptic receptors and, at the same time, permit (or even 
enhance) the activity of synaptic NMDAR. Contrary to expectations, we observed NR2B blockade amplified 
the degree of apoptosis that was seen after DEX treatment alone.  In the absence of supporting evidence to the 
contrary, we tentatively propose that since the NMDA/ifenprodil pre-treatment was transient (i.e. drugs were 
washed out after 15 min.), the effects observed reflect changes in the sensitivity  and/or synthesis of NR2B-
containing (death-promoting) receptors; this could include upregulation of NR2B during the subsequent 
exposure (72 h) to DEX alone. Other likely events include pre-treatment- or DEX-induced downregulation of 
NR2A-containing (pro-survival) NMDA.R. Another plausible explanation would be that by employing 
transcriptional mechanisms to elevate glutamate synthesis (cf. Ábrahám et al., 1996), DEX would effectively 
make more neurotoxic glutamate available to NMDA.R (containing NR2B subunits), thus positively driving a 
vicious circle. These findings showing the involvement of NMDA.R in the apoptotic actions of DEX, do not 
 necessarily exclude the possibility of direct, GR-mediated, apoptotic actions of DEX, as reported in Chapter 3. 
A model summarizing our views on how glucocorticoids and glutamate receptors interact to regulate the 
balance between hippocampal cell survival and death is depicted in the following figure. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 B. Pathways mediating TGF-β2 and BDNF signaling 
Studies focused on verifying the role of BDNF in the observed CMCerebellum-induced effects on hippocampal cell 
development (Chapter 2) included immunocytochemical demonstration that BDNF is strongly expressed in 
cerebellar cultures, but only weakly in hippocampal cultures. Treatment of hippocampal cultures with 
exogenous BDNF resulted in an inhibition of BrdU uptake and an increase in neuritic length as well as an 
increased MAP2ab-positive neuronal population. Transfection of cells with a BDNF-expressing plasmid 
provided similar results on BrdU incorporation. BDNF effects on neuronal differentiation are known to be 
mediated through TrkB receptors (Klein et al., 1991) and, depending on the strength and duration of the 
stimulus, BDNF either promotes or inhibits neuronal proliferation by activating the Trk-MEK-ERK pathway 
(Marshall, 1995; Du et al., 2003). The latter prompted us to examine whether TrkB or ERK signaling is 
involved in the biological actions of CMCerebellum, i.e. those ascribed to BDNF. Consistent with the literature, we 
observed that whether TrkB or ERK signaling is involved in the biological actions of CMCerebellum, i.e. those 
ascribed to BDNF. Consistent with the literature, we observed that blockade of TrkB by transfecting a 
dominant negative TrkB construct resulted in an attenuation of the pro-neuronal actions of CMCerebellum. In 
addition, blockade of MEK1/MAPK with UO126 also negated the actions of CMCerebellum, indicating the 
operation of more than a single mechanism or the convergence of several signaling pathways upon activation 
by a single ligand. These data contrast with previous findings that activation of ERK1/2 blocks the Smad 
pathway in Xenopus embryos (Pera, 2003); at present, we lack a plausible explanation for this discrepancy. 
Interestingly, however, as described in Chapter 2, BDNF treatment was shown to elicit a response from a TGF-
β reporter gene (3TP-Lux), and to mobilize Smad2 and Smad4, two key players in TGF-β signaling, from the 
cytoplasm to the nucleus in neuronal cultures. Thus, we tentatively hypothesize that BDNF may be able to 
activate the Smad pathway through ERK1/2-dependent phosphorylation through as yet undefined mechanisms. 
It is pertinent to note that other recent studies also alluded to BDNF-TGF cross-talk (Lutz et al., 2004) or 
interdependence/synergism (Unsicker and Strelau, 2000).  
 
Members of the TGF-β superfamily signal by sequentially binding to two TGFβ receptors (TGFβR) which are 
transmembrane protein serine/threonine kinases. In the case of TGF-β2, ligand binding to TGFβR-II activates 
TGFβR-I; both the developing and rat adult hippocampus express TGFβR-II mRNA (Böttner et al., 1996). 
Receptor-regulated SMAD proteins (R-SMADs) serve as TGFβR-I substrates which, upon phosphorylation, 
subsequently bind Co-Smad4 and translocate to the nucleus where they form a transcriptionally-active complex 
after association with DNA-binding partner(s). This last complex binds to promoter elements of target genes 
whose functions include regulation of the cell cycle, differentiation and cell adhesion, positioning, and 
movement (Moustakas et al., 2001; Chang et al., 2002; Shi and Massagué, 2003).  
 
TGF-β is a well-known inhibitor of proliferation, inducing cell cycle arrest by suppressing  the oncogene Myc, 
a repressor of the cyclin-dependent kinase inhibitors, p21 and p27 (Seoane et al., 2002; Gartel and Shchors, 
2003). In support of the view that the anti-mitogenic effects of CMCerebellum may be accounted for by TGF-β2 in 
the CM, we observed an upregulation of p21 and p27 after CMCerebellum treatment of proliferating hippocampal 
neurons (Chapter 2). Additional evidence for a key role of TGF-β2 in the hippocampal cell fate-determining 
actions of CMCerebellum was obtained in a series of experiments focused on the TGF-β signal-propagating SMAD 
proteins. Of the various SMAD proteins, Smad2 and Smad 3 mediate TGF-β signals. Smad4 is a requisite 
partner for transcriptional activity of  Smads2 and 3 (as well as Smads1, 5 and 8 which are BMP substrates); 
the generation of specific downstream responses is thought to depend on the formation of specific R-SMAD-
 Smad4 complexes which then recruit different sequence-specific DNA-binding factors (Massagué and Wotton, 
2000). Data reported in Chapter 2 demonstrate that CMCerebellum induces nuclear translocation of EGFP-fused 
Smad2 and Smad4. Results showing essential roles for Smad3 and Smad4, based on expression of the 
dominant negative forms, are also presented: these manipulations prevented the transactivation of 3TP-Lux by 
CMCerebellum and abrogated the anti-proliferative and pro-differentiating effects of CMCerebellum in hippocampal 
cultures. Further support for the notion that TGF-β2, at least partially, accounts for the anti-proliferative 
activity present in CMCerebellum is provided by the observation that expression of a vector containing a dominant 
negative form of TβRII in either primary hippocampal cells or a hippocampus-derived cell line (Hib5) results 
in a abolition of the CMCerebellum-induced effects on BrdU incorporation and 3TP-Lux reporter activity 
compared to control.  
  
A model showing the mechanisms underlying BDNF and TGF-β2 control of proliferation and differentiation of 
hippocampal and cerebellar granule cells is presented in the scheme shown below. 
 5.4. Summary and future directions 
The aims of the work undertaken for this thesis may be summarized as follows:  
• To identify factors which may be responsible for the differential developmental patterns followed 
by granule neurons in the hippocampus and cerebellum, and to analyse their signaling pathways 
(Chapter 2); 
• To examine the mechanisms underlying glucocorticoid-induced apoptosis in the hippocampus, in 
particular with regard to the role of glutamatergic transmission (Chapters 3 and 4).  
 
With respect to the first aim, the principal findings (Chapter 2) show that: 
• TGF-β2, supported by the Smad signaling machinery, plays a key role in determining hippocampal cell 
fate by inhibiting proliferation and, in parallel, inducing neuronal maturation.  
• BDNF, better known for Trk receptor-mediated promotion of neurogenesis and differentiation, exerts anti-
proliferative and pro-neuronal effects on developing hippocampal neurons by activating a MAP kinase 
cascade which ultimately converges onto the TGF-β signaling pathway. 
 
Results presented in Chapter 3 show that: 
• The glucocorticoid dexamethasone (DEX) can directly induce apoptosis in hippocampal cell cultures via 
the mediation of GR so long as neuroprotective MR are not occupied. However, the actions of 
glucocorticoids can be modulated depending on the prevailing state of glutamatergic transmission 
(Chapter 4, see below). 
• Suggestions in the literature that the apoptotic effects of DEX reflect the effects of ‘chemical 
adrenalectomy’ are therefore not tenable. 
• Mature, rather than immature, granule neurons are targeted by glucocorticoids for apoptosis.  
 
Studies on the likely interaction between glucocorticoids and glutamatergic transmission (Chapter 4) revealed 
that: 
• The apoptotic actions of DEX are, at least partly, mediated by GluR of the NMDA and metabotropic types. 
• Low doses of NMDA, acting via synaptic NMDAR can effectively block hippocampal cell death induced 
by DEX.  
• Gluccorticoids can cause apoptosis in hippocampal cells by triggering rapid (NMDA.R-mediated) as well 
as slow (mGluR- or GR-mediated) responses. The final outcome of glucocorticoid treatment on 
hippocampal cell survival depends on the convergence and integration of transcriptional signals and signals 
originating at the cell membrane. 
 
Here follow some considerations which may be pertinent to attempts to integrate the novel observations made 
in this work and to identify further lines of investigation.  
• Both the TGF-β and glucocorticoid signaling pathways contribute to the regulation of a variety of 
neurodevelopmental and physiological processes. For example, this work demonstrates that both factors 
inhibit proliferation of hippocampal granule cell progenitors, and other studies have demonstrated that 
they are both inducers of apoptosis in a variety of cell types (Schmidt et al. 2004; Zalavras et al., 2003; 
Druilhe et al., 2003; Lee et al., 2002; Siegel and Massague, 2003; Schuster and Krieglstein, 2002). These 
observations suggest that a certain degree of interaction between these pathways must exist in order to 
ensure manifestation of coordinated responses. Indeed, GR have been reported to inhibit TGF-β signaling 
 by directly targeting Smad3 in Hep3B cells and COS cells (Song et al., 1999; Li et al., 2003). On the other 
hand, TGF-β can block GR signaling through AP-1-mediated transcriptional repression in mouse 
fibrosarcoma L929 cells (Periyasamy and Sanchez, 2002). At the same time, glucocorticoids upregulate 
TGF-β mRNA expression in various cell types (AyanlarBatuman et al., 1991; Boulanger et al., 1995; 
Reyes-Moreno et al., 1995; Wang et al., 1995; Oursler et al., 1993) while the anti-proliferative effects of 
glucocorticoids are abrogated by TGF-β neutralizing antibodies (AyanlarBatuman et al., 1991; Johnson et 
al., 1993; Reyes-Moreno et al., 1995). To what extent these findings apply to the regulation of 
neurodevelopmental processes remains to be elucidated.  
• With respect to their mechanisms of action, recent evidence suggests that glucocorticoids can also act 
through pathways independent of binding of GR to glucocorticoid response elements (GRE) function 
through GRE (Di et al., 2003; Qiu et al., 2003; Evans wt al., 2003); similarly, apparently not all TGF-β 
actions are mediated through Smad pathways (Massague and Chen, 2000). It will be interesting to identify 
whether TGF-β and glucocorticoids share common signaling pathways which result in the inhibition of 
neurogenesis and stimulation of neuronal differentiation and/or apoptosis; in addition, their utilization of 
GRE- and Smad-dependent and/or GRE- and Smad-independent mechanisms will be worth investigating.  
• The first evidence of cross-talk between TGFβ and BDNF in the control of hippocampal granule cell 
maturation deserves more thorough analysis. In particular, it will be important to know whether the ability 
of BDNF to enhance the Smad signaling pathway results from its stimulation of ERK1/2 or indirectly, 
increased TGFβ secretion. Further, clarification is needed as to how ERK1/2 stimulates (rather than 
inhibits) Smad activity, and interactions of TGFβ with MAPK cascades also need further investigation.  
• Although TGFβ and BDNF were here identified as key molecules in the control of granule cell 
development, the involvement of other factors which might also fulfil such roles cannot be excluded. The 
application of more efficient CM screening (e.g. 2-D gel electrophoresis and MS-MS approaches and/or 
antibody array assays, will greatly facilitate the search for other candidates.  
• Recent studies have identified GR in mitochondria, organelles which are intimately involved in the 
apoptotic process (Koufali et al., 2003; Demonacos et al., 1995, 1996). The role of mitochondrial GR in 
DEX-induced neuronal cell death, conventionally ascribed to nuclear GR, deserves evaluation.  
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Summary  
Cell proliferation and death occur contemporaneously in the hippocampal dentate gyrus. On the premise that 
the positioning and survival of newly-born neurons are important determinants of hippocampal function, we 
here analyzed the topographical distribution of cell proliferation (bromodeoxyuridine incorporation) and 
apoptosis (morphological criteria and TUNEL histochemistry) in 1-month old rats. Our analysis included 
comparisons between left-right hemispheres, dorsal-ventral hippocampus and suprapyramidal-infrapyramidal 
blades of the dentate gyrus; since newly-generated cells appear in the subgranular zone (SGZ) before migrating 
inwards, we also compared the granular cell layer (GCL) versus SGZ. Highest proliferation indices were found 
in the SGZ (47%), followed by the GCL (29%), hilus (16%) and molecular layer (8%). Whereas proliferation 
rates did not differ between hemispheres, analysis along the rostro-caudal axis revealed higher cellular division 
in the ventral SGZ. In addition, gradients of proliferation were observed in the subdivisions of the GCL with 
the external, infrapyramidal and ventral zones showing highest proliferative potential. The total number of 
apoptotic cells was evenly distributed throughout the dentate gyrus, although the incidence of apoptosis 
decreased gradient-wise from the tip of the suprapyramidal layer and was highest in the external third of the 
GCL and lowest in its internal third, in marked contrast to the proliferation profile. Curiously, more apoptosis 
was observed in the left hippocampus. This study shows that neurogenesis and apoptosis occur in specific 
‘niches’ and provides a useful basis for future investigations into the relationship between hippocampal 
structure, function and plasticity.  
 Introduction 
New neurons are continually generated from a local population of stem or progenitor cells in the dentate gyrus 
of the hippocampus (Altman and Das, 1965; Cameron et al., 1993; Kuhn et al., 1996). Our previous 
stereological studies indicated that the total number of hippocampal granule cells increases by some 25% (ca. 
250,000 cells) during the first 6 months of life and by some 5% during the subsequent 6 months (Sousa et al., 
1999, 2000); these observations are commensurate with data showing that the rate of granule cell acquisition 
declines with increasing age (e.g. Kuhn et al., 1996; Kempermann et al., 1998; Cameron and McKay, 1999, 
2001; Nacher et al., 2003).  
The cytoarchitecture of the dentate gyrus ultimately results from neurogenesis and the concurrent physiological 
elimination of neurons through apoptosis (Gould et al., 1991; Lossi and Merighi, 2003). Interestingly, 
neurogenesis and neuronal apoptosis share a number of common regulatory factors, e.g. adrenal steroids and 
excitatory amino acids (Gould and McEwen, 1993; Cameron and Gould, 1994). This, together with the 
aforementioned temporal overlap strongly suggests that the two processes are intimately related and that the 
balance between them determines the rate of postnatal granule cell turnover. Despite numerous studies on 
neuronal birth and death in the postnatal dentate gyrus, there is a conspicuous lack of information with respect 
to the topographic distribution of proliferating and dying neurons (e.g. rostro-caudal, inter- and intra-layer and 
hemispheric asymmetry). Such maps could help promote our understanding (i) of why individual granule cells 
show differing electrophysiological properties (Wang et al., 2000), (ii) how specific functions result from the 
suprapyramidal vs. infrapyramidal and intra-layer positions of individual granule cells (Scharfman et al., 2002), 
(iii) what structural and neurochemical mechanisms operating during dentate development provide the ventral 
and dorsal hippocampus with functionally-distinct properties (Moser and Moser, 1998) and (iv) whether 
hemispheric asymmetry in granule cell turnover accounts for hemispherical differences in hippocampal volume 
and function in both rodents (Verstynen et al., 2001) and humans (Zaidel et al., 1998; Utsunomiya et al., 1999).  
 
In order to determine whether neuronal proliferation and death in the hippocampus occur according to 
subregion-specific patterns or in a stochastic fashion, we undertook a systematic stereology-based mapping of 
these events in young (1 month old) rats under basal conditions. Cell proliferation was assessed 
immunohistochemically after incorporation of the thymidine analogue bromodeoxyuridine (BrdU) into the 
DNA of cells in S-phase; apoptosis was evaluated using established morphological criteria coupled with 
terminal deoxynucleotidyl transferase-mediated dUTP-nick-end labeling (TUNEL) histochemistry. Disturbed 
granule cell proliferation is increasingly being proposed as one of the neurobiological mechanisms responsible 
for psychiatric and neurological disorders (Jacobs et al. 2000; Duman et al., 2001; Eisch, 2002). However, only 
one previous study (Ekdahl et al., 2001) has addressed the issue of likely concomitant cell death and none has 
studied subregion-specific changes in neuronal turnover. The information gained here will allow more critical 
analysis and exploitation of the factors directing birth and functional organization of dentate neurons.   
 
 Materials and Methods 
Animals 
Six male Wistar rats (Charles River, Barcelona, Spain), aged 4 weeks and with a mean weight of 120g, were 
used in this study. Animals were housed under standard laboratory conditions (12 hours light cycle; 22ºC, 55% 
humidity; food and water available ad libitum). Experiments were conducted in accordance with local 
regulations (European Union Directive 86/609/EEC) and NIH guidelines on animal care and experimentation. 
 
Tissue preparation 
Rats received daily intraperitoneal injections of 50 mg/kg BrdU (Sigma, St. Louis, MO) on 3 consecutive days 
and were killed by rapid decapitation 24 hours after the last injection. Brains were carefully removed, placed in 
cryoprotectant and snap-frozen in liquid nitrogen. Serial coronal sections (20 µm), extending over the entire 
length of the hippocampus, were obtained using a cryostat and mounted on poly-L-lysine-coated slides.  
 
Histochemical procedures  
BrdU labelling 
BrdU incorporation was detected by immunocytochemistry on every 8th section (Fig. 1A). Briefly, sections 
were fixed in 4% paraformaldehyde (PFA) for 30 minutes, permeabilized for 10 minutes in a solution 
containing 0.2% Triton X-100 in Tris buffer saline (TBS), microwaved (20 minutes) while immersed in citrate 
buffer (0.1 M), and acidified in 2 M HCl (30 minutes). Endogenous peroxidase activity was blocked with 3% 
H2O2 in TBS (10 minutes) and non-specific staining was blocked with 4% bovine serum albumin (BSA) in 
TBS (30 minutes). Subsequently, sections were incubated overnight with a mouse monoclonal anti-BrdU 
(1:100, Chemicon, Temecula/California). Antigen visualization was carried out using a universal detection 
system (BioGenex, San Ramon, CA) and diaminobenzidine (DAB: 0.025% and 0.5% H2O2 in Tris-HCl 0.05M, 
pH 7.2). Specimens were lightly counterstained with hematoxylin. 
TUNEL 
One out of eight sections containing the hippocampal formation was used for TUNEL histochemistry (Fig. 1B). 
Sections were fixed as described above, permeabilized in a two-step procedure (0.1% trypsin in PBS, pH 7.2 at 
37 ºC, followed by 0.1% Triton X-100 in PBS, 5 minutes at room temperature) and treated with 3% H2O2 in 
PBS (3 minutes) to block endogenous peroxidases. Sections were then pre-incubated in terminal 
deoxynucleotidyl transferase (TdT) buffer before incubation (37º C, 1 hour) in a cocktail consisting of 13.5 µL 
TdT (MBI Fermentas, Hanover/MD ), 6.75 uL dUTP-Biotin (Roche, Basel/Switzerland), 90 µL TdT buffer, 20 
µL TdT enzyme buffer (MBI Fermentas) and 770 µL distillate water. Development and visualization was 
achieved using a commercial avidin-biotin/DAB system (Vector Labs, Burlinghame, CA). Hematoxylin was 
used as a counterstain. 
 
Stereological procedures 
Estimates of cell density in the different subdivisions of the hippocampus were obtained using the optical 
fractionator method in combination with the StereoInvestigator software (MicroBrightField, Williston/VT). 
Briefly, each 8th section was used for sampling the different areas of interest. Starting at a random position, 
visual fields were sampled by step-size movements of 150 µm in the x-axis and 200 µm in the y-axis for all 
subdivisions analyzed, except the hilus (Hl) and molecular layer (MCL) in which the step-size was 350 µm in 
both axis. Counting frames areas were 625 µm2 at tissue level. Cells were counted under a x100 lens, thus 
obtaining a resolution sufficient to easily identify the different layers and cells types. Cellular discrimination 
 was based on morphological and staining criteria: apoptotic cells were identified by TUNEL coloration and, in 
addition, by their small size, chromatin condensation, and vesicular formation; cells that were positively 
labeled with BrdU were considered as cells which had been recently generated, i.e. within the timeframe of the 
experiment. 
The following criteria were used to define transversal divisions within the granular cell layer (GCL) and 
subgranular zone (SGZ): the angular subdivision (Ang) was considered as the area extending from the tip of the 
crest up to the end of its curve; the remaining area was divided into two equal parts, delineating the 
intermediate (Med) and extreme (Ext) subdivisions (Fig. 1C). These subdivisions were further distinguished in 
terms of their position within the suprapyramidal (Supra) and infrapyramidal (Infra) blades. Longitudinal 
divisions of the GCL (internal, intermediate and external) were defined by dividing the thickness of the GCL 
into 3 equal parts. The SGZ was considered to be a 4-cell-body-wide zone at the border between the GCL and 
Hl. The division between dorsal and ventral hippocampus was based on the relative position of the dentate 
gyrus with respect to the third ventricle or cerebral aqueduct: areas located superior to a transverse plane 
passing at the top of these structures were considered dorsal, whereas those located inferior were considered 
ventral. 
 
Statistical analysis  
Results are expressed as mean + SEM. SEM and coefficient of error (CE) were calculated accordingly to 
Gundersen and Jensen (1987). Data were analyzed using one- or two-way analyses of variance (ANOVA), 
followed by Tukey post-hoc multiple comparisons. Differences were considered statistically significant if p≤ 
0.05. 
 
 Results  
Volumes of the dentate gyrus 
Analysis of the volumes of the different layers of the left dentate gyrus revealed a slight, but not significant 
(F(7,47)= 0.097; p=0.8), predominance of the left dentate gyrus (Table 1). Yet, a significant effect of location 
along the rostral-caudal axis was revealed by ANOVA (F(7,47)= 32.1; p≤ 0.0005). Comparisons between dorsal 
and ventral divisions showed increased volumes in the dorsal component of the molecular cell layer (MCL), 
granular cell layer (GCL), subgranular zone (SGZ), except in the hilus (Hl) where the volume of the ventral 
division outweighed that of the dorsal division (Table 1). 
BrdU staining  
As illustrated in Fig. 2A, significant differences (F(3,23)= 237.8; p≤ 0.0005) were observed in the total number of 
BrdU-positive cells within the various divisions of the dentate gyrus: molecular cell layer (MCL), granular cell 
layer (GCL), subgranular zone (SGZ) and hilus (Hl). The ratio of cellular proliferation was as follows: 
subgranular zone >> granule cell layer >> molecular cell layer = hilus. 
Whereas no significant hemispherical differences in the densities of BrdU-incorporating cells were detected in 
any of the divisions of the dentate gyrus (Fig. 2B), there were significant differences in proliferation along the 
rostro-caudal axis of this hippocampal subfield (F(3,23)= 56.6; p≤ 0.0005). Post-hoc comparisons revealed that 
mitotic cells predominate in the ventral SGZ (Fig. 2C).  
As shown in Fig. 2D, ANOVA revealed a significant effect (F(3,23)=416.5; p≤ 0.0005) of location of 
proliferating cells into supra- and infra-pyramidal blades, as well as in subdivisions of the dentate gyrus (F(3,23)= 
49.7; p≤ 0.0005). Post-hoc comparisons demonstrated a significant increase in the numerical density of BrdU-
labeled cells in the infra-pyramidal blade of both areas (Fig. 2D).    
Within the GCL, proliferation was higher in the internal third of the cell layer (F(2,15)= 238; p≤ 0.0005) (Fig. 
2E)]. 
Analysis of the densities of BrdU-positive cells in the GCL and SGZ sub-divisions revealed a significant effect 
of location within supra- vs infra-pyramidal blades (F(5,35)= 57.9; p≤ 0.0005) and in the transversal position 
within these blades (F(5,35)= 4.3; p= 0.03). A gradient of proliferation increasing from the extreme portion of the 
suprapyramidal blade to the angular zone of the infrapyramidal blade was found, with a decrease from the 
angular zone to the extreme portion of this blade (Fig. 2F).  
Apoptosis 
As illustrated in Fig. 3A, and confirmed by ANOVA (F(3,23)=14.5; p≤ 0.0005), analysis of densities of apoptotic 
cells between the main divisions of the dentate gyrus showed the GCL and SGZ to have the highest levels of 
apoptosis (Fig. 3A). In addition, a significant effect of hemispheric location (F(7,47)=12.4; p=0.001) was 
detected by ANOVA; comparisons for potential differences between hemispheres revealed that apoptotic cells 
were more abundant in the left dentate gyrus, although the differences were significant only in the SGZ (Fig. 
3B). 
There were no significant differences (F(7,47)= 1.3; p=0.27 ) in the occurrence of apoptosis along the rostro-
caudal axis of the dentate gyrus (Fig. 3C). ANOVA revealed an effect of location of apoptosis in the supra- and 
infra-pyramidal blades (F(3,23)= 415; p≤ 0.0005), as well as in the subdivisions of the dentate gyrus (F(3,23)= 
49.5; p≤ 0.0005), with higher levels of apoptosis in the supra-pyramidal blade of the GCL (Fig. 3D). Scrutiny 
of the sublayers within the GCL revealed an increasing gradient of apoptosis from the internal third to the 
external third of the GCL (F(2,17)= 381.4; p≤ 0.0005) (Fig. 3E). Further, it was found a significant effect of both 
supra- vs infra-pyramidal blade location (F(5,35)=5.0; p=0.003) and transversal position within these blades 
 (F(3,23)=3.4; p=0.04) for apoptotic cells; post-hoc comparisons demonstrate that the highest index of apoptosis 
occurs in the extreme portion of the supra-pyramidal blade (Fig. 3F). 
 Discussion 
Granule cell turnover 
The postnatal dentate gyrus displays remarkable plastic properties, reflected, for example, by its ability to 
generate new granule cells from progenitors cells located in the SGZ throughout life (Altman and Das, 1965; 
Cameron et al., 1993; Kuhn et al., 1996). Despite a decline in proliferative potential with increasing age, 
postnatal neurogenesis contributes significantly to the number of granule cells, with estimates of an additional 
1500-9000 new granule cells being born each day (Biebl et al., 2000; Cameron and McKay, 2001; Fisher et al., 
2002) but the net increase in the volume and total cell number of the dentate gyrus during postnatal life is 
considerably smaller due to the continuous loss of granule cells through apoptotic mechanisms (Sousa et al., 
1998, 1999).  
The programmed elimination of cells is an essential component of the neural cell turnover process and is 
important for the shaping and maintenance of brain structures (Raff et al., 1993; Burek and Oppenheim, 1996; 
Rubin, 1997). Hippocampal granule cells undergo apoptosis during postnatal development and aging and 
following exposure to various stimuli (Gould et al., 1991; Sloviter et al., 1993; Gould and Cameron, 1996; 
Hassan et al., 1996; Almeida et al., 2000). Under basal conditions, the rates of neurogenesis and apoptosis 
show a strong inverse correlation during development and early life, and tend to equalize thereafter. It is thus 
conceivable that an inappropriate balance in these rates will predispose the individual to pathology, including 
accelerated aging of the neural substrate and impaired function. Supporting the view that neurogenesis and 
apoptosis occur in a coordinated and inter-dependent fashion are the facts that the two phenomena occur in 
tandem and share several intrinsic and extrinsic triggers (e.g. Gould and McEwen, 1993; Cameron and Gould, 
1994; Lossi and Merighi, 2003).  
The starting premise for this study was that evidence for differential occurrence of these events could 
eventually contribute to improving understanding of the relationship between structure and function. 
Accordingly, we here aimed to determine gradients and laterality in the incidence of neurogenesis and 
apoptosis in the dentate gyrus of the young male rat, rather than to establish the precise daily ratio between 
neuronal birth and death in this hippocampal area; while the latter would demand a different experimental 
design because of the complex dynamics of each of these events, the protocol that was used allows comparison 
with the majority of published studies pertaining to the issue examined in this paper.  
 
Topographical specificity of proliferation 
A major objective of this study was to analyze the precise location and extent of neurogenesis and apoptosis in 
the dentate gyrus. Our results show that proliferating cells are predominantly located in the SGZ and the 
adjacent (inner third) GCL, confirming observations by Kempermann et al., (2003). Further, this topographical 
analysis revealed that the density and total number of newly-generated cells is greater in the ventral than in the 
dorsal hippocampus, and greater in the infrapyramidal than in the suprapyramidal blade of the dentate gyrus. 
The prevailing consensus is that newly-generated cells migrate inwards from the SGZ, reaching their final 
location within a few days-weeks of birth, where they ultimately differentiate (e.g. Kempermann et al., 2003). 
Assuming a role for paracrine factors and synaptic inputs in differentiation, it is highly plausible that location 
plays a crucial role in determining the final functional phenotype of newly-born granule cells. Generation of 
cellular diversity is perhaps the most intriguing question of brain development, and there are numerous 
examples of phenotypically-similar neurons displaying differing functions, presumably because of subtle 
differences in topography and the physicochemical characteristics of the niche in which individual cells find 
themselves (e.g. Green and Juraska, 1985; Claiborne et al., 1990; Scharfman et al., 2002).  
 Natural and induced postnatal neurogenesis is increasingly being implicated in improved hippocampal function 
(e.g. see Kempermann, 2002; Korovitskiy and Gould, 2003). In this respect, the positional aspects discussed 
above increase in importance given that, as the organism ages, new neurons are acquired and incorporated into 
neuronal networks of ever-growing complexity. The herein reported data provides the first systematic and 
quantitative evidence for topographical differences in the incidence of granule cell turnover; appreciation of 
these subtle patterns in the distribution of newly-generated and apoptotic neurons should facilitate a better 
definition of structure-function relationships under healthy and pathological states.  
 
Apoptosis as a counterbalance to neurogenesis 
The demonstration that the topographic distribution of apoptosis and neuronal proliferation in the dentate gyrus 
differ significantly was unexpected given that neurogenesis and apoptosis in this area share several common 
stimuli. In contrast to the distribution of proliferating granule cells, apoptotic cells were predominantly found in 
the suprapyramidal blade. While adrenalectomy-induced apoptosis was previously shown to mainly occur in 
this blade (Sloviter et al., 1993; Sousa et al., 1997), the current findings are the first to demonstrate such a 
skewed distribution under basal conditions, and suggest the particular susceptibility of granule cells in this 
subdivision to apoptosis. Since apoptosis significantly contributes to neural tissue reorganization (Raff et al., 
1993; Burek and Oppenheim, 1996; Rubin, 1997) and may underlie reduced hippocampal volumes in 
pathological states (Lupien et al., 1999; Honig and Rosenberg, 2000; Friedlander, 2003; Sheline et al., 2003), 
the role of subregion-specific neuronal loss to the plasticity and function of the hippocampus deserves critical 
assessment in the future. Although at this age neurogenesis exceeds apoptosis in terms of absolute numbers, 
apoptosis, driven by changing external and internal conditions, is likely to be an integral component of normal 
granule cell turnover, ensuring structural stability and appropriate connectivity. Our findings point to the 
necessity of considering apoptosis when evaluating the potential pathologic and therapeutic roles of 
neurogenesis.  
 
Hemispherical asymmetry in incidence of apoptosis  
Our observation that neurogenesis occurs to an equal extent in both the left and right hippocampal formations 
whereas the degree of apoptosis is greater in the left hippocampus bolsters the notion that apoptosis has a 
significant impact on hippocampal structure and function. Under basal conditions, standard morphometric and 
magnetic resonance imaging analyses revealed that the right hippocampus of the male rat is thicker (Diamond 
et al., 1982) and has a greater volume than its left counterpart. Interestingly, these hemispherical differences 
can be permanently manipulated by exposing rats to certain stimuli during postnatal development (Verstynen et 
al. 2001). Whether the present finding - that there is a greater incidence of apoptosis in the left hippocampus - 
can explain these differences waits more rigorous testing. Meanwhile, it is pertinent to mention that the loss of 
a relatively small number of granule cells is reflected in a major decrease in hippocampal volume owing to the 
concomitant loss of neuritic extensions (Sousa et al. 2000).  
Asymmetry in hippocampal volumes in humans appears to be a consistent finding; according to one study, up 
to 91% of healthy subjects have larger right hippocampal formations (Utsunomiya et al., 1999). The potential 
importance of this asymmetry may be reflected in clinical data which strongly indicate a higher incidence of 
certain psychiatric disorders (e.g. post-traumatic stress disorder and major depression) in subjects with smaller 
absolute and normalized left hippocampal volumes (Bremner et al., 1997; Mervaala et al., 2000). Lending 
support to this are the findings that (i) mood scores correlate negatively with left hippocampal volumes 
(Villarreal et al., 2002), (ii) the normal left-right differences in hippocampal volume are exaggerated in patients 
 with affective disorders (Mervaala, et al, 2000), and (iii) early life events, which have been causally implicated 
in psychopathology (Gutman and Nemeroff, 2003; McEwen, 2003), selectively reduce the size of the left 
hippocampus (Teicher et al., 2003).  
 
Concluding remarks 
The herein reported data serves to alert researchers to the potential importance and functional implications of 
topographical differences in the incidence of granule neuron proliferation and death in the hippocampus. 
Further, the reported findings provide a much-needed basis for relating the neurodevelopmental positioning of 
proliferating and dying cells to the final functional phenotype displayed by individual granule cells.  
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Table 1. Volumes of the subdivisions of the dentate gyrus in left and right hemispheres (mm3)  
 
 
Values are expressed as mean (SEM). No significant differences are found between the values of left versus 
right subdivisions of the dentate gyrus. Comparisons between dorsal and ventral subdivisions of dentate gyrus. 
Left hemisphere: MCL: p≤ 0.0005; GCL: p=0.001; SGZ: p= 0.002; Hl: p= 0.008. Right hemisphere: MCL: p≤ 
0.0005; GCL: p≤ 0.0005; SGZ: p≤ 0.001; Hl: p≤ 0.002. Mean CE= 0.04.  
Left 
  Dorsal Ventral Total 
ML 2.15 (0.02) 1.59 (0.06) 3.74 
GCL 0.52 (0.01) 0.39 (0.02) 0.91 
SGZ 0.30 (0.01) 0.22 (0.01) 0.52 
Hl 0.64 (0.03) 0.83 (0.04) 1.47 
  Right   
  Dorsal Ventral Total 
ML 2.03 (0.06) 1.48 (0.07) 3.51 
GCL 0.51 (0.02) 0.36 (0.02) 0.87 
SGZ 0.28 (0.01) 0.21 (0.01) 0.49 
Hl 0.62 (0.01) 0.80 (0.04) 1.42 
  
Figure legends 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Photomicrographs illustrating the localization of (A) BrdU immunoreactive cells (arrowheads) and (B) 
TUNEL positive cells (arrowheads) in dentate gyrus. Scale bar: 50µm. (C) Representation of the dentate gyrus 
divisions including the transversal subdivisions used for the cell counting with the StereoInvestigator software. 
Molecular cell layer (MCL), granular cell layer (GCL), subgranular zone (SGZ) and hilus (Hl). Scale bar: 350µm. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 (A) Graphic representation of the distribution of BrdU-positive cells in the dentate gyrus divisions: 
molecular cell layer (MCL), granular cell layer (GCL), subgranular zone (SGZ) and hilus (Hl). Comparisons 
among divisions showed SGZ as having the highest levels of BrdU-positive cells followed by GCL. GCL vs 
MCL: p≤ 0.0005; GCL vs SGZ: p≤ 0.0005; GCL vs Hl: p≤ 0.0005; SGZ vs MCL: p≤ 0.0005; SGZ vs Hl: p≤ 
0.0005. Mean CE=0.04. (B) Total number of BrdU-positive cells in left and right dentate gyrus (DG). Mean 
CE=0.05. (C) Comparison between cellular proliferation in dorsal and ventral hippocampus. SGZ: p≤ 0.0005. 
Mean CE=0.05.  (D) Analysis of the densities of BrdU-positive cells between the supra- (Supra) and infra-
pyramidal (Infra) blades. GCL: p≤ 0.0005; SGZ: p≤ 0.0005. Mean CE=0.02. (E) Distribution of BrdU-
incorporating cells within GCL longitudinal subdivisions. The highest mitotic levels were found in the internal 
sublayer. External vs Internal: p≤ 0.0005; Intermediate vs Internal: p≤ 0.0005. (F) Comparison of the densities 
of BrdU-positive cells between transversal subdivisions of the GCL and SGZ revealed Inf Ang as having the 
highest levels of mitosis. This sub-division is statistically different from all the others sub-division with the 
exception of Inf Intmed. Inf Ang vs Sup Ext: p≤ 0.0005; Inf Ang vs Sup Intmed: p≤ 0.0005; Inf Ang vs Sup 
Ang: p≤ 0.0005; Inf Ang vs Inf Ext: p≤ 0.0005. Mean CE=0.03. * p≤ 0.005 
 Fig. 3 (A) Graphic representation of the distribution of apoptotic cells in the dentate gyrus (DG) divisions: molecular cell layer 
(MCL), granular cell layer (GCL), subgranular zone (SGZ) and hilus (Hl). GCL vs MCL: p=0.002, GCL vs Hl: p=0.006; SGZ vs 
MCL: p≤ 0.0005; SGZ vs Hl: p≤ 0.0005. Mean CE=0.07. (B) Comparison between total number of apoptotic cells in left and right 
subdivisions of the dentate gyrus. SGZ: p≤ 0.0005. Mean CE=0.13. (C) Comparison of densities of apoptotic cells in dorsal vs 
ventral hippocampus. Mean CE=0.10. (D) Analysis of apoptotic cells density in granular supra- (Supra) and infra-pyramidal 
(Infra) cell layer in GCL and SGZ. GCL: p≤ 0.0005. Mean CE=0.07. (E) Analysis of apoptotic cell level in GCL longitudinal 
subdivisions. This comparison showed a gradient from internal to external layers and external layer as having the highest apoptotic 
levels. External vs Internal: p≤ 0.0005; External vs Intermediate: p≤ 0.0005; Intermediate vs Internal: p≤ 0.0005. (F) Comparison 
of apoptotic cells between transversal divisions in GCL and SGZ indicates superior external as having the highest levels of 
apoptosis. Sup Ext vs Sup Intmed: p=0.006; Sup Ext vs Sup Ang: p=0.0005; Sup Ext vs Inf Ang: p≤ 0.0005; Sup Ext vs Inf 
Intmed: p=0.006; Sup Ext vs Inf Ext: p=0.038. Mean CE=0.07]. * p≤ 0.005 
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